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“Yolunda yürüyen bir yolcunun, yalnız ufku görmesi kâfi değildir. Muhakkak ufkun 





“The traveler not only has to see the path but also the horizon behind it.” 
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 The thymus provides the stromal microenvironment crucial for the development of T 
cells. Thymic epithelial cells (TEC) constitute the most abundant cellular component of the 
thymic stroma and are indispensable for T cell generation, selection and maturation. TEC are 
classified into cortical (c) and medullary (m) epithelia based on their distinct anatomical 
locations, molecular phenotypes and functional features. MicroRNAs (miRNAs) are post-
transcriptional regulators of gene expression that play crucial roles in numerous biological 
processes including cell fate determination, self-renewal, differentiation, proliferation and 
apoptosis. The importance of miRNA for TEC biology is reflected in the observation that 
miRNA-deficient TEC display defects in committing hematopoietic precursors to a T cell fate, 
mediating thymocyte positive selection and effecting normal promiscuous gene expression 
required for central tolerance induction. Lethal-7 (Let-7) miRNAs are the most abundant 
miRNAs in the genome, constitute a family of 10 conserved isomiRs encoded on different 
chromosomes and are critically involved in cell differentiation. Let-7 miRNAs are negatively 
regulated by the RNA binding proteins (RBPs) Lin28A and Lin28B. Both paralogues inhibit 
the generation of mature Let-7 transcripts and in addition regulate gene expression via direct 
mRNA target-binding, thus controlling multiple cellular processes such as development, cell-
cycle control, differentiation, apoptosis and metabolism. However, the role of the Lin28/Let-7 
axis is unknown for TEC development, function and maintenance. To investigate the 
importance of this axis, I expressed either Lin28A, Lin28B or both gene products in TEC using 
tissue-directed transgenesis. Lin28A and Lin28B differentially regulated thymic organ size, 
TEC maturation and function under the experimental condition doses. Thymic hypoplasia and 
hyperplasia were prominent findings in Lin28A and Lin28B transgenic mice, respectively. 
Their corresponding thymic size correlated with the number of early thymic progenitors (ETP) 
   ii 
detected thus reflecting opposing roles for Lin28A and Lin28B. Both RBPs mediated changes 
in the mTEC subset composition whereas the cTEC compartment was only altered in Lin28A 
mutant animals. The changes in the composition of cTEC imposed by Lin28A impaired the 
positive and cortical negative selection of thymocytes. In adult mice, Lin28A mediated the 
persistence of phenotypically immature cTEC, that are more stringent in regulating thymocyte 
positive selection than cTEC with a mature phenotype. Finally, I show that Lin28A enhances 
glucose metabolism of cTEC and induces TEC apoptosis through tumor necrosis factor receptor 
1 (TNF-R1) signaling. Taken together, this work demonstrates that Lin28A and Lin28B 
expression differentially affect both thymus development and function despite their comparable 
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1.1 The history of the Thymus 
The immune system plays a crucial role in protecting the body against a vast number 
of harmful challenges, including microbial pathogens and other diseases, a function which is 
dependent on the ability to discriminate between vital “self” and injurious “non-self”. This 
competence is acquired by T lymphocytes in the thymus, the last organ in our body that 
revealed its essential role in health and disease. The first direct references to the thymus as an 
organ were noted by the Greek physicians Rufus of Ephesus and Galen of Pergamum circa 
100-200 AD. They believed the thymus to be the “Seat of the soul” because of its close vicinity 
to the heart as well as its aura of mystery that surrounded it [1]. In the Middle Ages, the thymus 
gland was largely ignored, though some believed the organ to be a protective cushion for the 
vasculature of the chest cavity. The crucial milestone in disentangling the thymus physiology 
was marked in the 17th century with the invention of the first microscope, when the surgeons 
William Hewson and Arthur Hill Hassall identified the lymphatic nature of the thymus through 
histological analyses. By the late 1950s, the thymus’ importance in the immune system was 
well recognized [2]. It would, however, take the efforts of the immunologist Jacques Miller in 
1961 to ultimately understand the importance of the thymus in regulating the immune response. 
In a series of experiments, Miller observed that the surgical removal of the thymus in neonatal 
mice resulted in a deficiency of a lymphocyte population, later named as T cells [3]. In the 
subsequent years, the combined work of several scientists has revealed critical roles of the 
thymus in processes such as positive selection [4], negative selection of auto-reactive T cells 
[5] as well as the generation of regulatory T cells (Treg) [6]. The detailed understanding of 




development of novel technologies, like single cell RNA sequencing, has enabled discoveries 
of so far unknown mechanisms regulating thymic organogenesis and function. 
 
 
1.2 Anatomy of the Thymus 
The thymus is a primary lymphoid organ of jawed vertebrates which is located in the 
upper anterior thorax adjacent to the heart and consists of two separate lobes that are connected 
to each other via an isthmus. The thymus consists to 99% of developing T cells, known as 
thymocytes, whereas only 1% of cells make up the stromal compartment. Within the thymus 
stroma thymic epithelial cells (TEC) play a crucial role in supporting T cell development by 
producing soluble and cell-bound factors which are needed to navigate thymocytes through the 
different stages of T cell development. The thymus stroma, however, also consists of non-
epithelial cells, such as mesenchymal cells, B cells, dendritic cells (DCs), macrophages, 
vascular and peri-vascular cells that collectively contribute to T cell development [7, 8]. 
The thymus microarchitecture includes two spatially and functionally distinct regions, 
namely an outer cortex and an inner medulla, which are separated by the cortico-medullary 
junction (CMJ) [9]. The majority of the thymocytes, are situated in the outer cortical region 
rendering this compartment heavily packed with developing T lymphocytes. The cortex is 
marked by a scaffold of thymic epithelial cells that create a mesh-like organization providing 
a large cell surface area allowing the simultaneous interaction of an individual cortical (c) TEC 
with several thymocytes. One of the key roles of cTEC is to provide survival signals to useful 
thymocytes (i.e. express a T cell receptor (TCR) that weakly interacts with peptide/self-MHC 
molecule complexes). In parallel, cTEC are capable to instruct the elimination of possibly  
dangerous cells (i.e. cells with a TCR able to strongly interact with peptide/self-MHC 
complexes) [10]. Other cell types present within the cortex are macrophages responsible for 




TEC and endothelial cells providing the portal for the entry of hematopoietic progenitor cells 
into the thymus and the exit of naïve T cells into the periphery [11, 12, 13]. In contrast to the 
cortex, the medulla is less densely populated as only a small number of thymocytes access this 
compartment consequent to the selection in the cortex which removes the majority of 
thymocytes. Medullary (m) TEC have a less sponge-like structure than cTEC and present a 
nearly complete repertoire of self-antigens in order to eliminate auto-reactive thymocytes [14, 
15]. The medulla contains additional antigen presenting cells, such as B cells and dendritic 
cells, which are able to acquire autoantigens and present them to developing thymocytes and 
hence contribute to the depletion of self-reactive cells [16, 17, 18]. Taken together, the thymic 
stroma provides a specialized microenvironment that fosters the development and selection of 
functionally competent T cells.  
 
1.3 Thymus Organogenesis 
Organogenesis of the thymus is a well-organized sequence developmental steps that are 
closely tied to the formation of the parathyroid glands (Figure 1). Both organs arise bilaterally 
at around embryonic day 10.5 (E10.5) from the endodermal lining of the ventral aspect of the 
third pharyngeal pouch (3rdpp) which is surrounded by neural crests cells (NCCs) that support 
the outgrowth of the primordium [7] (Figure 1). Parallel to the extension of this early structure, 
the expression of the transcription factor Forkhead box protein N1 (Foxn1) starts in the 
dorsoventral region of the primordium at around E11.25 [19]. Simultaneously, the expression 
of the transcription factor Glial cells missing 2 (Gcm2) is initiated in the adjacent part of the 
primordium. The expression of these two transcription factors delineates the separate areas of 
the primordium with distinct developmental fates: Foxn1 controls the construction of the 
thymic epithelial scaffold while Gcm2 regulates parathyroid differentiation. Although Foxn1 




their fate determination (i.e. lineage commitment). Thus, once epithelia from the 3rdpp have 
committed to the TEC fate, Foxn1 drives the cells’ further development and function. In 
addition, Foxn1 is crucial for the maintenance of the thymic organ and its decline in expression 
contributes to thymic involution. It is to be noted that Foxn1 is also expressed in the skin where 
it is responsible for the robustness of hair shafts [20, 21]. Reflecting the functional role of 
Foxn1, mice deficient for this transcription factor (Foxn1 gene is located at the nude locus, 
hence these animals were designated as nude; “nu/nu” mice as they have little to no hair) still 
make a rudimentary and cystic thymus anlage that lacks the ability to attract blood-borne 
lymphoid progenitors to foster the cells development to T cells [21]. At E12.5, the common 
anlage has given rise to a separate thymic lobe and a parathyroid gland in each side of the neck. 
In the subsequent development of the thymus, the interaction of multiple cell types is essential, 
including the neural crest cells, mesenchymal cells, endothelial cells, TEC and hematopoietic 
cells, especially maturing thymocytes. Neural crest cells hereby support the development of 
the thymic capsule and the trabeculae while mesenchymal cells are required for epithelial cell 
proliferation though the production of fibroblast growth factors (Fgf)-7 and -10 as well as 
retinoic acid (RA) and insulin-like growth factor (Igf)-1 and -2  [22, 23, 24]. Endothelial cells 
play an important role in the seeding of the thymus with blood-borne lymphoid progenitors as 
the cells expressing lymphotoxin beta receptor (LTβR), the adhesion molecules P-selectin, 
VCAM-1 and ICAM-1 whereas their corresponding ligands are expressed on early thymic 
progenitors (ETP) [12, 25, 26]. ETP enter at E12.5 the still avascular thymus anlage via 
migration through the capsule of the developing organ [27, 28, 29]. Between embryonic days 
12 and 14, a next wave of precursor cells seeds the thymus and fosters TEC development by 
signaling through several tumor necrosis factor receptor superfamily (TNFRSF) members, 














Figure 1: Current model of the thymus organogenesis   
(a) At embryonic day 9.5 (E9.5), the thymus starts to develop from the outgrowth of the third 
pharyngeal pouch together with the parathyroid. The paired box genes (Pax) 1 and 9 as well as 
fibroblast growth factor (Fgf) 8 are hereby necessary for pharyngeal pouch formation while the 
expression of homeobox A3 (Hoxa3) is required for specifying organ identity within the 3rd 
pharyngeal pouch. (b) At E11, the outgrowing of the rudiment begins. The Hox-Pax-Eya-Six cascade 
is required the development of the endodermal cells (in yellow) whereas Hoxa3a, Eya1 and Six1 are 
also expressed in neural crest cells and thus might be important for proper thymus development 
(NCC). (c) At E11.5-12.5, the fate of the endodermal cells into thymic or parathyroid cells is decided 
by the mutually exclusive expression of Foxn1 and Gcm2, respectively. Thymic cells express Foxn1 
(displayed in blue) while Gcm2 (shown in red) is expressed in parathyroid cells.  (d)  During E12-
13.5, Pax9 drives the detachment of the thymic rudiment and parathyroid structure from the pharynx. 
In addition, Hoxa3, Hoxb3 and Hox3d initiate the separation and migration of the thymus primordium 
from the parathyroid. (e) From E12-birth the development of a functional thymus is also dependent 
on the interaction of the thymus organ primordia with different factors from surrounding cells and the 






1.4 Thymic epithelial cell development and heterogeneity 
TEC differentiation is a dynamic process that is initiated during embryonic 
development and continues after birth (Figure 2) [34]. Despite the anatomical and functional 
differences between cTEC and mTEC, both develop from a common thymic epithelial 
progenitor cell (TEPC) [35]. The existence of these progenitors was first suggested by the 
identification of cells which are located at the cortico-medullary junction in postnatal mice and 
that stained positively for cytokeratins 8 (CK8; a classical cortical marker) and 5 (CK5; a 
characteristic marker for medullary epithelia), respectively [36, 37]. Further evidences for the 
presence of TEPC came from experiments showing that the microinjection of single enhanced 
yellow fluorescent protein (eYFP)-tagged E12.5 TEC into embryonic wild-type thymi gave 
rise to both cTEC and mTEC lineages [38].  
The developmental connection between the seemingly distinct cTEC and mTEC 
lineages was further corroborated by in vivo cell lineage tracing experiments using a 
fluorescent reporter gene triggered by a doxycycline-inducible Cre recombinase under the 
transcriptional control of the Psmb11 promoter. Psmb11 is a gene which encodes the cortical 
TEC-specific β5t catalytic subunit of the thymoproteasome [39].  Hence, this fate-mapping 
system was used to mark TEC that have expressed β5t at any time subsequently to 
constitutively express an enhanced green fluorescent protein (eGFP). The work by Ohigashi 
and others inferred that TEPC express β5t and that these progenitor cells first acquire 
characteristics of cTEC (i.e. expressing CD205, β5t and IL-7) before committing to the mTEC 
differentiation pathway [40]. Because eGFP was detected in the vast majority of mTEC in 
young mice but these cells lack β5t expression, this finding implied that most mTEC at this age 
are derived from β5t positive progenitors. Additional studies localized these mTEC precursors 




After lineage divergence into cTEC or mTEC, immature TEC to up-regulate the 
expression of MHCII. Cortical and medullary TEC can hereby be distinguished using a set of 
well-defined markers, namely Ly51, CD205, CK8 and β5t for identifying cTEC and CK5, 
CD86, Autoimmune regulator (Aire) and reactivity for Ulex Europaeus Agglutinin 1 (UEA1) 
for delineating mTEC. Experimental evidence further suggests that the differentiation into the 
mTEC lineage requires the activation of the nuclear factor-kB (NF-kB) signaling pathway 
which is initiated by interactions of mTEC progenitors with hematopoietic cells. Specifically, 
CD4 single positive thymocytes influence mTEC differentiation via signals including CD40L, 
Lymphotoxin-beta (LTβ) and Receptor Activator of NF-kB Ligand (RANKL) [42, 43, 44, 45, 
]. Parallel to MHCII up-regulation, developing mTEC increase their surface levels of co-
stimulatory molecules including CD80 and CD86 and attain a phenotype defined to as mature 
mTEC once they express Aire [45]. 
This historical view of TEC development and heterogeneity has, however, recently 
been challenged by single cell RNA sequencing (scRNA-seq) studies. These analyses have 
identified at least 9 distinct cTEC and mTEC subtypes whose frequencies dynamically change 
over the life course [46, 47, 48, 49]. In addition, biocomputational approaches allowed to 
establish developmental trajectories between individual TEC subtypes that can be analysed 
under different experimental conditions to probe not only changes in the heterogeneity of the 
TEC stromal compartment but to also interrogate precursor::progeny relationships. 
These transcriptomic studies have provided evidence that the classical segregation of 
TEC into cTEC and mTEC constitutes a simplification based on available cell surface markers 
used in flow cytometry. In effect, these two TEC subsets are highly heterogenous and are likely 

















Figure 2: Thymic epithelial cell development and heterogeneity    
(a) Historically, the two main TEC subpopulations were differentiated using a set of surface markers, 
such as UEA-1 (for mTEC) and Ly51 (for cTEC) and MHCII, CD80 and CD86 (for the separation of 
immature from more mature TEC developmental states). However, recent single cell genomic 
technologies have been used to show that TEC are highly heterogenous and comprise multiple 
subpopulations. (b) In the embryonic and neonatal thymus, a common β5t-expressing TEC progenitor 
can give rise to cTEC and mTEC. While the commitment into the cTEC lineage occurs by default, 
the differentiation into the mTEC lineage requires nuclear factor- kB (NF-kB) signaling. In adult 
mice, however, the existence of a bipotent TEC is still under debate. Abbreviations: AIRE, 
autoimmune regulator; CCL21, CC-chemokine ligand 21; cTEPC, cTEC progenitor; DLL4, delta-
like ligand 4; jTEC, junctional TEC; KRT10, keratin type I cytoskeletal 10; mTEPC, mTEC 






1.5 T cell development 
The thymus is the site for T cell formation and selection. T cell development comprises 
a series of maturational processes within the thymic microenvironment and is initiated with the 
recruitment of T lymphoid progenitors from the blood, also known as thymus seeding. These 
blood-borne progenitors enter the thymus as early as E12.5 in a vasculature-independent 
manner and in post-natal mice via the well-developed vasculature at the cortico-medullary 
junction of the thymus [50, 51]. The seeding of the thymus is orchestrated by the expression of 
CC-chemokine ligand 25 (CCL25), CXC-motif-chemokine 12 (CXCL12) which are mainly 
expressed by cTEC and CC-chemokine ligand 21 (CCL21), CC-chemokine ligand 19 (CCL19) 
which are produced by mTEC [52]. Moreover, thymus settling of these hematopoietic 
precursors is also regulated by the interplay of platelet (P)-selectin glycoprotein ligand 1 
(PSGL1) expressed on T lymphoid progenitors with P-selectin present on the thymic 
endothelium [25]. However, the entry of progenitors into the thymus is not a continuous 
process but rather happens in two successive waves, one between E11-E14 and the second at 
E18 [53]. The mechanisms behind this intermittent process are, however, yet unknown.  
Upon thymus entry, these blood-borne progenitors give rise to ETP which start their 
maturation as CD4 and CD8 double negative (DN) cells. DN maturation can be phenotypically 
followed using the cell surface expression of CD25, the IL-2 receptor α-chain, CD71, a 
transferrin receptor essential for iron uptake and CD44, a glycoprotein involved in cell-cell 
interactions, adhesion and migration. The maturational trajectory of DN development starts 
with cells that express CD44 but lack CD25 and CD71 expression (designated as DN1) and is 
followed by a stage that expresses CD44 and CD25 but is CD71 negative (designated DN2). 
Subsequently, these thymocytes gives rise to cells that only express CD25 (DN3a) which is 
followed by a stage that is CD25 and CD71 positive (DN3b). The development of DN1 to DN3 




receptor c-kit, a transmembrane tyrosine kinase which upon interaction with SCF expressed by 
cTEC promotes the proliferation of these immature thymocytes [54, 55].  Moreover, cTEC also 
express Delta like ligand 4 (Dll4), which commits ETP to the T cell lineage engaging Notch 
signaling in DN1 and DN2 cells [56]. These initial maturational steps of DN1 to DN3 also 
depend on survival signals provided by cTEC in the form of interleukin-7 (IL-7) [57, 58]. 
Parallel to their development, DN thymocytes also migrate from the CMJ to the sub-capsular 
zone, a process controlled by numerous chemokine receptors including C-X-C chemokine 
receptor type 4 (CXCR4, recognizing CXCL12), C-C chemokine receptor 7 (CCR7, 
recognizing CCL19 and CCL21) and CCR9 (recognizing CCL25) [59, 60, 61]. As part of this 
interaction, DN1, DN2 and DN3 thymocytes also regulate cTEC differentiation although the 
exact signals provided for this phenomenon remain yet elusive [37].  
Concomitant to the relocation towards the subcapsular region, DN cells start to 
rearrange their TCRß-locus. During this process of somatic gene recombination, individual 
gene segments of variable (V), diversity (D) and joining (J) region within the TCRß-locus are 
recombined by a machinery of nuclear enzymes, including the recombination-activating genes 
(RAG) 1 and 2. The successful and productive (i.e. in-frame) recombination results in the 
generation of a locus that encodes a complete TCRß-chain with unique antigen specificity [62].  
DN3 and DN4 cells are then characterized by the surface expression of a pre-TCR composed 
of a complete ß-chain that associates with an invariant pre-TCRα chain. Only those DN3 cells 
which have successfully rearranged ß-chain and thus express a functional pre-TCR will receive 
survival signals in a process known as ß-selection and are enabled to differentiate further [63]. 
Cells passing the ß-selection checkpoint also undergo a proliferative burst and continue their 
maturation by down-regulating CD25 to attain a DN4 stage. Subsequently, these cells start to 
express CD8 to become CD8 immature single positives (CD8 ISP) before up-regulating CD4 






Figure 3: Schematic representation of T-cell development and selection    
Hematopoietic precursors are recruited to the thymus via blood vessels near the cortico-medullary 
junction. Guided by chemokines from the thymic stroma, these progenitors relocate to the cortex, 
commit to a T cell fate and start to rearrange their TCRß-locus. The initial stages of T cell maturation 
lack the expression of the co-receptors CD4 and CD8 expression (termed as double negatives, i.e. 
DN) and can be phenotypically followed using the cell surface expression of CD25 and CD44 (termed 
as DN1 to DN4). Upon successful TCRß rearrangement and subsequent expression of a functional 
pre-TCR, developing T cells receive survival signals and up-regulate CD4 and CD8 to attain a double 
positive (termed DP) stage. DP cells that have a TCR with strong affinity to self-antigens are removed 
from the T cell repertoire in a process called negative selection. Thymocytes that generated a TCR 
with intermediate affinity to self-peptide/MHC experience a positive selection signal and can develop 
further while the rest dies by neglect. Subsequently, thymocytes down-modulate one of the co-
receptors to enter the SP stage in the medulla. The remaining self-reactive thymocytes undergo further 
negative selection by mTEC. Finally, thymocytes that completed all the selections steps enter the 






The newly generated DP rearrange their TCRα-locus to express heterodimeric 
TCRα/TCRβ chains together with the CD3 complex on the cells’ surface. At this 
developmental stage, thymocytes are probed for the functionality of their TCR specificity when 
binding peptide/MHC-complexes expressed on the surface of cTECs [64]. This stage marks 
the second checkpoint of thymocyte development, whereby the strength of TCR binding to 
peptide/MHC-complexes determines the fate of these DP cells. Collectively, a number of 
studies have resulted in the so called affinity model of T cell selection that explains the outcome 
of this important process as a function of the receptors affinity to its cognate ligand (Figure 4) 
[15]. The majority of DP thymocytes express a TCR with low or no affinity to peptide/MHC-
complex. Consequently, the necessary survival signals are not received by these thymocytes 
and a cell-intrinsic process of programmed cell death is not prevented. As a consequence, these 
thymocytes will undergo apoptosis in a process known as “death by neglect”. On the other 
hand, cells having a TCR that mediates the interaction to self-MHC plus peptide complexes 
with intermediate affinity will survive. This quality check is referred to as positive selection 
and ensures the further maturation of cells. Thymocytes with high TCR affinity are removed 
from the repertoire in a process called “negative selection” which is mediated by the up-
regulation of the pro-apoptotic molecule Bim through protein kinase C [15]. Other thymocytes 
display TCR affinity which confers sufficient binding strength to escape negative selection but 
that is nonetheless higher to what is required for the escape of programmed cell death by 
conventional effector cells. This alternative selection process has been termed “agonist 







Positively selected thymocytes transiently express the early activation marker CD69 
and down-module the expression of the co-receptors CD4 and CD8, also known as “dulling” 
[67]. Thereafter, these thymocytes will commit to the separate CD4 or CD8 lineages, 
depending on the class of MHC recognized. While DP cells that bind MHC II down-regulate 
CD8 surface expression to become CD4 single positive (SP), MHC I recognition promotes 
CD4 down-modulation and subsequent maturation into CD8 SP [68, 69]. However, the 
generation of CD4 and CD8 SP is an sequential process where CD4 SP arise before CD8 SP 
[68].  Although it was suggested that the co-receptors have different transcriptional activities, 
the exact molecular mechanisms behind the asynchrony of CD4 and CD8 differentiation are 
yet unknown. The earliest CD4 SP subset (designated SM, semi-mature) is CD24 positive and 
still localized in the cortex due to lack of a cell surface expression of the CC-chemokine 
receptor 7 (CCR7) [70]. CCR7 binds to the two chemokine ligands 19 (CCL19) and 21 
Figure 4: The affinity model of T cell selection    
Newly generated TCR are being tested for their affinity to self-peptide/MHC-complexes. The 
majority of thymocytes do not recognize peptide/MHC-complexes and “die by neglect”. Cells baring 
a TCR with intermediate affinity are positively selected and continue their maturation while 
thymocytes with high binding strengths are negatively selected and removed from the repertoire. As 
there is no sharp affinity threshold for positive and negative selection of cells there is a range at which 
some thymocytes are stochastically selected and usually develop into the Treg lineage. (Image stems 






(CCL21), that in the thymus are predominantly produced by mTEC, and control the access of 
the cells from the cortex to the medulla [60]. Once in the medulla CD4 SP thymocytes up-
regulate the expression of CD69 (achieving a developmental stage designated mature 1, M1). 
Subsequently, these cells down-modulate CD69 and CD24 expression and attain a fully mature 
phenotype (designated mature 2, M2) equipped to produce cytokines and to proliferate upon 
activation. Mature CD8 SP thymocytes are exclusively detected in the medulla where they first 
adopt a CD69+CD24+ stage (M1) before down-regulating both of these markers to develop a 
mature (M2) phenotype. 
Thymocytes that express a TCR with high affinity to tissue restricted antigens (a.k.a. 
“self-peptides”) receive an apoptotic signal and undergo negative selection. This process 
promotes central tolerance and is important to remove potentially auto-reactive cells from the 
repertoire [71]. The first negative selection event occurs in the cortex (designated wave 1) and 
is followed by a second negative selection which occurs in the medulla (known as wave 2) 
[72]. Thymocytes subjected to wave 1 are identified by the co-expression of the transcription 
factor Helios and the programmed cell death protein 1 (PD-1) whereas those of wave 2 are 
phenotypically recognized by Helios [72].  
In the medulla, thymocytes spend approximately 12 days before they are sufficiently 
mature to exit the thymus [73, 74]. During this sojourn, SP cells are also being tested for both 
ubiquitous and tissue restricted antigens (TRA) presented by mTEC to remove the remaining 
auto-reactive cells. The expression of a variety of peripheral tissue self-antigens is mediated 
by a subpopulation of mature mTEC and involves the expression of the transcription factor 
Autoimmune Regulator (Aire). Another group of medullary cells, namely dendritic cells (DCs), 
also contribute to the process of negative selection by cross-presenting mTEC derived TRAs 
[75]. Moreover, medullary thymic B cells purge negative selection by presenting self-antigens 




Once having successfully survived all selection steps and completed all maturational 
stages, thymocytes exit to the periphery as mature and functionally competent naïve T cells. 
The egress of these mature cells happens via the perivascular space and is controlled by G-
protein coupled sphingosine-1-phosphate receptor 1 (S1P1) [51]. Thymic emigrants join the 
pool of peripheral T cells capable to mount an immune response to foreign antigens whilst 




1.6 Thymic epithelial cell function 
cTEC are responsible for the attraction of hematopoietic precursors to the thymus, their 
commitment to the T cell lineage, their subsequent survival, expansion and early maturation 
including the decisive steps of positive and first wave of negative selection. One characteristic 
that distinguishes cTEC from other antigen presenting cells (APC) is the possession of a 
specific molecular machinery by which peptides are processed and presented in the context of 
MHC class I and class II molecules. For example, cTEC express a unique proteasome known 
as thymoproteasome as its β5 subunit is replaced by a tissue-specific variant designated β5t. 
The expression of β5t in cTEC catalyzes a unique set of MHC-I associated peptides that are 
important for the positive selection of CD8 SP thymocytes [76]. Moreover, cTEC express 
proteases such as Cathepsin L (Ctsl) and thymus specific serine proteases (TSSP) which are 
involved in the processing of antigens to peptides that are presented in the context of MHC-II 
molecules (Figure 5). Both peptide producing pathways influence the efficacy by which CD4 
SP thymocytes are generated as their deficiency impairs positive selection [77, 78]. 
 
One of the major roles of mTEC is to guarantee a comprehensive negative selection of 
thymocytes with a high affinity receptor for TRA. Crucial to this function of mTEC is the 




derived from TRA. The promiscuous expression of TRAs is achieved by the transcriptional 
facilitator Aire, which in the thymus is exclusively expressed in a subset of mature mTEC 
(MHCIIhi Sca-1int) [79]. The transcription factor Forebrain Embryonic Zinc Finger-like 2 
(Fezf2), has also been implicated in TRA expression by mTEC [80]. In addition to expressing 
a large number of self-peptides, mTEC also express co-stimulatory molecules CD80 and CD86, 
which complement the peptide/MHC derived signals and contribute to the signaling in 




Figure 5: Antigen presentation in TEC requires unique proteolytic machineries 
Endogenous proteins are degraded by proteasomes and the resulting peptides are transported into the 
ER and loaded on MHC class I molecules. The peptide/MHC complex is then transported to the cell 
surface where it can be detected by thymocytes. The proteasomes can contain different subunits in 
different cell types. MHC class II molecules acquire their peptides mostly through macroautophagy 
derived lysosomes in TEC. Various lysosomal proteases process proteins derived from 






1.7 The role of microRNAs and their importance in TEC biology 
MicroRNAs (miRNAs) are a class of small (19-25 nucleotides), single stranded, non-
coding RNAs that function as post-transcriptional gene regulators and have been implicated in 
many different biological processes, including cell development, self-renewal, proliferation, 
metabolism and apoptosis [82]. The biogenesis of mature miRNA involves a series of catalytic 
processes steps, including the cleavage of primary (pri) and precursor (pre) miRNA molecules 
by endoribonucleases Drosha and Dicer, respectively [82]. Mature miRNAs, together with 
Argonaute proteins, form a multiprotein complex, known as RNA-induced silencing complex 
(RISC). Guided by the miRNA via base-pairing, the miRNA-RISC complex binds to the 3’ 
untranslated region (3’UTR) of target messenger RNAs (mRNAs) and enforces a translational 
repression or the cleavage and degradation of the mRNA (Figure 6) [82].  
The collective importance of miRNA for TEC biology was shown for example, in TEC 
deficient for the RNA-processing enzyme Dicer. TEC devoid of miRNAs fail to maintain a 
normal thymic architecture, are unable to commit hematopoietic precursors to a T cell fate and 
display defects in thymocyte positive and negative selection [83]. The impact of single 
miRNAs on TEC biology was also revealed using transfections of miR-181a into mTEC which 
resulted in a higher proliferation rate of these cells [84]. Furthermore, the development of 
mature mTEC (i.e. MHCIIhi) is impaired in mice where the activity of miR-449a is inhibited 
[85]. Finally, a TEC-restricted ablation of miR-155 impairs the development and function of 
mTEC in fostering Treg maturation [86]. Although these studies provided evidence for the 
importance of miRNAs in TEC biology, the exact functional roles of the majority of the 






















1.8 The Let-7 family of miRNAs 
The most abundant miRNA family is Lethal-7 (Let-7), which was discovered in the 
nematode Caenorhabditis elegans (C. elegans) and is highly conserved across animal species.  
Unlike C. elegans, higher animals have multiple (10-14) Let-7 isoforms whereby each isoform 
is encoded on different chromosomes. All of these isoforms share the same consensus 
sequence, called the “seed sequence”, which is crucial for the binding to target mRNAs [87]. 
The expression of the Let-7 family has been shown to be indispensable for terminal cell 
differentiation. Undetectable in progenitor cells, Let-7 isoforms accumulate during cellular 
differentiation and target transcripts of several stemness factors for degradation thus inhibiting 
self-renewal and promoting cell differentiation [88]. Besides its involvement in stem cell 
regulation, Let-7 has also been shown to suppress cancer development and progression by 
negatively regulating the expression of proteins with oncogenic potentials, such as Rat sarcoma 
Figure 6: Schematic representation of miRNAs biogenesis and function  
Primary miRNA (pri-miRNA) molecules are produced by RNA polymerase before being processed 
by the microprocessor-complex Drosha-DGCR8 in the nucleus. The resulting precursor miRNA (pre-
miRNA) is then translocated into the cytoplasm via Exportin-5 and further processed by the 
ribonuclease Dicer to generate mature miRNA. The functional strand of the mature miRNA is then 
associated with the silencing complex (RISC), where it guides RISC to silence target mRNA 






(RAS), high-mobility group AT-hook 2 (HMGA2), c-Myc and cyclin-D2 [89]. Moreover, Let-
7 is also involved in the regulation of glucose metabolism in multiple organs and its disruption 
results in insulin resistance and impaired glucose tolerance [90].  
 
1.9 The RNA binding protein Lin28 
The Let-7 family of miRNAs is negatively regulated by the RNA binding protein (RBP) 
Lin28. Lin28, like Let-7, was first discovered in C. elegans and described as a promoter of 
pluripotency critical during embryonic development. Differing to Let-7, Lin28 is highly 
expressed early during cell development and declines in response to signals driving cellular 
differentiation (Figure 7). Thus, Lin28 promotes an uncommitted, undifferentiated cell fate 
whilst acting in parallel as a gatekeeper of the transition from a pluripotent stage to a committed 
cell lineage. In addition, and independently of an effect on Let-7 biogenesis, Lin28 also directly 
binds to numerous mRNAs coding for molecules involved in diverse cellular functions, 
including proliferation and metabolism. Let-7 itself also binds to the 3’ UTR of Lin28 mRNA 
and block its translation, thus forming a negative feedback loop [91].  
Figure 7: The Lin28/Let-7 feedback axis in cell development 
During cell development, Lin28 is highly expressed in progenitor cells and blocks the biogenesis of 
mature Let-7 miRNAs, hence maintaining the expression of genes that induce self-renewal and 
proliferation. Concomitant to cellular differentiation, Lin28 expression decreases, allowing the 
production of mature Let-7 molecules. Subsequently, Let-7 represses the expression of genes involved 







1.10 Isoforms and structure of Lin28 
There are two paralogues of Lin28, namely Lin28A and Lin28B, which share an amino 
acid sequence identity of 77%. Both regulate protein expression by controlling Let-7 family 
miRNA biogenesis and by binding to target mRNAs consequently altering their translation. 
Both Lin28 RBPs are highly conserved across many species and harbor a unique combination 
of distinct RNA-binding motifs, a cold-shock domain (CSD) and two cysteine cysteine 
histidine cysteine (CCHC) zinc finger domains (ZFD) (Figure 8) [91]. The CSD domain is 
crucial for initial pri- and pre-Let-7 binding as it induces conformational changes and allows 
the binding of the zinc finger domains to pri- and pre-Let-7, respectively. The binding of Lin28 
to mRNA strongly depends on the interaction of ZFD with a conserved “GGAG”-like motif 
present on hairpin loops of target mRNAs [92, 93, 94]. In contrast to Lin28A, Lin28B contains 
an extended tail region at its C-terminus and has additional nuclear and nucleolar localization 
sequence (NLS and NoLS, respectively). Hence, Lin28A is predominantly located in the 
cytoplasm while Lin28B is enriched in the nucleus, which has functional ramifications as 







Figure 8: Lin28A and Lin28B protein structures 
Lin28A and Lin28B have high sequence identity and comprise multiple common domains, namely a 
cold shock domain (CSD, displayed in blue) and two cysteine cysteine histidine cysteine (CCHC, 
shown in green) zink finger domains. Lin28B has, in addition, a nuclear localization signal (NLS) and 






1.11 Lin28 RBPs regulate gene expression via two distinct biological pathways 
1.11.1 Let-7 dependent functions of Lin28 
The inhibition of Let-7 biogenesis is currently the best described mechanism of Lin28 
mediated epigenetic regulation. Lin28 RBPs associate with the bulging “GGAG”-motif in the 
terminal loop of pri- and pre-Let-7 molecules and block their further processing. However, due 
to their distinct subcellular localization, Lin28A and Lin28B differ in their mechanism of 
inhibiting Let-7 processing. In the nucleus, Lin28B binds to pri-Let-7 and blocks its processing 
by the microprocessor complex Drosha:DGCR8. In contrast, Lin28A, which is primarily 
located in the cytoplasm, associates with pre-Let-7 and block its further cleavage by the 
ribonuclease Dicer. This interaction also mediates the terminal oligo-uridylation of pre-Let-7 
molecules which induces their degradation (Figure 9) [87]. Although Lin28A is mainly 
localized in the cytoplasm, and Lin28B predominantly found in the nucleus, they can both 
shuttle between those two subcellular compartments and target pri- and pre-Let-7, respectively 
[88, 89].  
 
1.11.2 Let-7 independent functions of Lin28 
In addition to the negative regulation of Let-7 biogenesis, both Lin28A and Lin28B are 
able to directly bind to target mRNAs and modulate their translation by recruitment of RNA 
helicase A to polysomes and/or control mRNA stability through their RNA-binding domains 
(Figure 9) [91, 96, 97]. As an example, the increased expression of Lin28A enhances the ability 
of muscle cells to use glucose as an energy source through up-regulation of multiple 
components of the Insulin-PI3K-mTOR pathway, including Insulin receptor (Insr), Insulin-like 
growth factor 1 receptor (Igf1r) and Insulin receptor substrate 2 (Irs2). In contrast, a loss of 
Lin28A expression results in insulin resistance and impaired glucose tolerance in these cells 




Lin28A controls the differentiation of skeletal muscle cells through directly enhancing the 
expression IGF-2, an important growth and maturation factor in these cells [99]. Finally, two 
studies found that Lin28A promotes the proliferation of embryonic stem cells in part by binding 
to and increasing the expression of cell cycle related genes, such as cyclin A and B and cyclin 
dependent kinase 4 (CDK4) [99, 100]. On the other hand, Lin28B inhibits apoptosis in ovarian 
cancer cells by directly decreasing the expression of the pro-apoptotic B-cell lymphoma 2 (Bcl-
2) family protein Bim [102]. Although it is still unclear how Lin28 confers specificity when 
targeting mRNAs, it seems that it primarily associates with hairpin structures in its targets, 
similar to its interaction with Let-7. Specifically, it was shown that Lin28 recognizes 
“AAGNNG” (N=A, C, G or U), “AAGNG” and less frequently “UGUG”, that are localized in 
the terminal loop of small hairpin structures and thus suppresses the translation of mRNAs 
destined for the endoplasmic reticulum (ER) [103]. In sharp contrast to this mechanism, 
Lin28:mRNA interactions were also demonstrated to promote protein synthesis through 
recruitment of  RNA helicase-A and translation initiation factor elF3-beta to polysomes [104]. 










Let-7 dependent functions of Lin28 Let-7 independent functions of Lin28 
Figure 9: Lin28 RBPs regulate gene expression via two distinct biological pathways 
Lin28 binds to both pri- and pre-Let-7 and blocks their further processing (Left). In the nucleus, Lin28 
associates with pri-Let-7 and inhibits its processing by the Drosha-DGCR8 complex. In the 
cytoplasm, Lin28 binds to pre-Let-7 to blocks its processing by Dicer and instead induces oligo-
uridylation and subsequent degradation of pre-Let-7. Lin28 also regulates gene expression by directly 
binding to and altering mRNA translation (Right). However, it remains unclear how Lin28 mediates 
these distinct functions. For example, Lin28 was shown to increase translation by recruitment of RNA 
helicase-A and translation initiation factor elF3-beta to polysomes. In addition, Lin28 is known to 









1.12 Roles of Lin28 in human diseases 
Consistent with the functions of Lin28 in controlling cell development, proliferation 
and metabolism, Lin28 activity was identified as a modulator of various human diseases, 
suggesting that Lin28:mRNA interactions are effective drug targets. For example, Lin28A was 
shown to be of therapeutic importance for patients with sickle cell anemia, as the over-
expression of Lin28A in cultured, sickle-cell shaped erythrocytes significantly reduced their 
pathogenic morphology [105]. Moreover, the forced expression of Lin28A in mouse adult 
tissues, enhanced their repair capacities by fostering a metabolic state characteristic of 
embryonic stem cells [106]. Here, the over-expression of Lin28A resulted in an enhanced digit 
repair, epidermal hair regrowth and pinnal tissue repair, implying to use Lin28A for repairing 
damaged and degenerated tissues. Also, a recent study showed that a loss-of-function variant 
of Lin28A contributes to Parkinson’s disease pathogenesis which can be rescued by re-
expression of a functional Lin28A, suggesting that future personalized therapies may target 
this variant in Parkinson’s patients [107]. Lastly, the de-regulation of Lin28 expression in some 
tumors promotes enhanced invasiveness, tumor growth, and thus worsens their prognosis [106, 
107, 108, 109, 110, 111]. Key to these effects seems to be the Lin28-mediated control of cell 
proliferation, leading to more aggressive tumors.  Indeed, the enforced expression of Lin28A 
promotes breast cancer cell growth via post-transcriptional stimulation of human epidermal 
growth factor receptor 2 (HER2) which in turn mediates cell proliferation [108]. Likewise, high 
expression of Lin28B in oesophageal cancer cells promotes tumor aggressiveness which is 
mediated through increased cell division rates as knock-down of Lin28B in these cells reduced 
their proliferative activity [109].  
helicase-A and translation initiation factor elF3-beta to polysomes. In addition, Lin28 is known to 






2. HYPOTHESIS AND AIMS 
 
The Lin28/Let-7 regulatory feedback loop controls cell differentiation, developmental 
timing, growth, tissue homeostasis and energy utilization, thus regulating the transition from 
undifferentiated to differentiated cell states. In addition to the modulation of miRNA 
biogenesis, Lin28 regulates translation via direct mRNA binding and/or the control of RNA 
stability.  
The hypothesis underpinning the experimental work presented in this study assumes that 
the Lin28/Let-7 feedback axis is essential for TEC biology and its disruption impairs the cells' 
maturation, metabolism and function. 
 
This experimental work presented here addresses the objective to identify the roles and 
underlying molecular mechanisms of Let-7 miRNA and Lin28 in TEC biology. 
 
Mice were generated that over-express Lin28A, Lin28B or both RBPs in a TEC-restricted 
fashion to ablate Let-7 function in thymic epithelia. Although this approach does not allow to 
dissect the function of individual Let-7 isomiRs, it enables me to study the general roles of the 
Let-7 family of miRNAs and to investigate Let-7 independent pathways affected by Lin28 











3. MATERIALS AND METHODS 
 
3.1 Generation of Lin28 transgenic mouse models 
Rosa26 knock-in mice containing the CAG-loxP-stop-loxP-Lin28a/Lin28b sequences 
(designated Lin28aCtrl and Lin28bCtrl, respectively) have been designed by Saule Zhanybekova, 
Johannes Schulte, Leonid Pobezinsky and Alfred Singer comparably to previously described 
Cre-dependent mouse lines [114]. These two mouse lines were crossed to animals expressing 
Cre recombinase under the transcriptional control of Foxn1 regulatory elements to obtain 
heterozygous mice ectopically expressing either Lin28a or Lin28b specifically in TEC 
(designated Lin28aTEC and Lin28bTEC). To obtain mice that express both Lin28a and Lin28b, 
Lin28aTEC and Lin28bTEC mice were crossed to create triple transgenic animals (Lin28axbTEC). 
All animals were kept under specific pathogen-free conditions and experiments were carried 
out in accordance with local and national regulations and permissions. 
 
3.2 Mouse Genotyping 
Toes of 1 - 2 week old mice were clipped and placed into 500 µl lysis buffer (0.1 M 
Tris adjusted to pH 8.5 (Sigma-Aldrich), 5 mM EDTA (Sigma-Aldrich), 0.2 M NaCl (Sigma-
Aldrich), 0.4% SDS (Sigma-Aldrich), 100 µg/ml Proteinase K (Amresco).  Samples were 
subsequently incubated for at least 2 hours at 56°C in a thermal shaker at 750 rpm and diluted 
with ddH2O (1:2). To define the mouse genotype a 1X PCR reaction mixture was prepared: 
 Lin28a              Lin28b & Foxn1Cre    
10x PCR buffer  2.5 µl 
dNTPs 0.5 µl 
Primers 
forward and reverse 
0.5 µl 
RNase, DNase free 
H2O 
19.9 µl 
Taq polymerase 0.1 µl 
DNA 1 µl 
 
10x PCR buffer 2.5 µl 
dNTPs 0.5 µl 
Primers 
forward and reverse 
0.5 µl 
RNase, DNase free 
H2O 
20.4 µl 
Taq polymerase 0.1 µl 















The resulting PCR products were mixed 5:1 with 6x DNA loading Dye and run in a 1.5% 





3.3 Flow cytometry analysis reagents 
Antibodies were conjugated with allophycocyanin (APC), Alexa Fluor 488 / 
fluorescein isothiocyanate (FITC), Alexa Fluor 647 (A647), Alexa Fluor 700 (A700), biotin, 
Brilliant Violet dyes BV421, BV510, BV605, BV650, BV786, cyanin 5 (Cy5), phycoerythrin 
(PE) or tandem dyes APC-Cy7, PE-Cy7, peridin chlorophyll protein (PerCP)-Cy5.5 and PE-
Texas Red. Biotinylated antibodies were detected with fluorophore-conjugated streptavidin. 
Other fluorescent reagents that were used were 4’,6-diamidino-2-phenylindole (DAPI), 2-
deoxy-2-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]-D-glucose (2-NBDG), MitoTracker 
DeepRed and Zombie dyes Zombie Red, Zombie Violet and Zombie Aqua.  
94°C 5 min. 
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Lin28b GTGACATTGACATCCACTTTGC CCCAAGGCACACAAAAAACC 
Foxn1Cre TCTGATGAAGTCAGGAAGAACC GAGATGTCCTTCACTCTGATTC 
 Lin28a                   Lin28b & Foxn1Cre  
 
















IA/IE (MHCII)  
APC-Cy7  
M5/114.15.2  BioLegend  
PerCP-Cy5.5 









CD274 (PD-L1) PE 10F.9G2 BioLegend 
Activated 
Caspase-3 
V450 C92-605 BD 
Total Caspase-3 A700 31A1067 Novusbio 
BrdU APC PRB-1 BD 
Puromycin A647 12D10 Merck 
Glut4 PE Polyclonal Novusbio 
TNF-R1 PE 55R-170 Santa Cruz 
Phospho-TAK1 
(Thr184/187) 
Rabbit IgG K.846.3 Life technologies 
Phospho c-Jun 
(pS63) 
A647 KM-1 Santa Cruz 
CD3 A647 KT3 Self-made 
CD4 PE-eFluor610 RM4-5 eBioscience 





CD24 PerCP-Cy5.5 M1/69 BioLegend 






PE-TxRed 30-F11 Life technologies 
A700 M1/9.3.3.HL Self-made 





CD71 PE-Cy7 RI7217 BioLegend 
CD117 (ckit) APC 2B8 BioLegend 
CD197 (CCR7) BV421 4B12 BioLegend 










3.4 Cell isolation and analysis with flow cytometry  
For analyses of TEC, thymic lobes from postnatal mice were harvested and cleaned of 
remaining fat and connective tissues. The lobes were subsequently separated, cut into cuboids 
and transferred into IMDM without fetal calf serum (FCS). The cells were gently rocked at 
room temperature on a shaker/rocker and supernatant was removed (2 x 3 min.). The cuboids 
were thereafter incubated in phosphate buffer saline (PBS) containing Liberase (200 μg/ml, 
Roche Diagnostics), DNaseI (20 μg/ml, Roche Diagnostics) and Papain (0.5 mg/ml, Sigma) 
Foxp3 PE  FJK-16s eBioscience 
Helios APC 22F6 eBioscience 
IL-2 PE JES6-5H4 BioLegend 
CD279 (PD-1) BV786 29F.1A12 BioLegend 
TCR ß 
APC 
H57-597 BioLegend FITC 
Biotin 
TCR γδ PE GL3 BioLegend 
CD11b Biotin M1/70 BioLegend 
CD11c Biotin N418 BioLegend 
CD19 Biotin ID3 Self-made 
F4/80 Biotin BM8 BioLegend 
Gr1 (Ly6G) Biotin RB6-8C5 BioLegend 
Ter119 Biotin Ter119 BioLegend 
MHCI Biotin AF6-120.1 BioLegend 
Streptavidin BV650 - BioLegend 
Anti-Mouse IgG A555 - Molecular probes 
Anti-Rabbit IgG 
A488 
- Molecular probes 
A750 
DAPI - - Invitrogen 
2-NBDG - - ThermoFisher 
MitoTracker 
DeepRed 
- - ThermoFisher 
Zombie 
BV510 
- BioLegend BV421 
PE-TxRed 





for 45 min. at 37ºC. Cells were gently pipetted up and down every 10 min. to obtain a single 
cell suspension and transferred into IMDM, containing 10% FCS and 10 mM EDTA 
(Invitrogen). After centrifugation, cells were filtered through a nylon mesh (100micron pore 
size, Sefar Nitex) to remove debris and counted using a Z1 Particle Counter (Beckmann 
Coulter). Due to the scarcity of TEC, cells were magnetically enriched for EpCAM with 
biotinylated G8.8 antibody and anti-biotin microbeads using AutoMACS Pro (Miltenyi Biotec) 
according to the protocol of the manufacturer. The enriched fraction was subsequently counted 
and stained with antibodies for 20 min. on ice in PBS containing 2% FCS. For intracellular 
staining, cells were fixed and permeabilized using either Cytofix/Cytoperm Kit (BD 
Biosciences) or eBioscience transcription factor staining buffer set (Invitrogen) and labeled 
with antibodies for 1 hour on ice.  
Single-cell suspensions of thymus, lymph nodes and spleen were obtained by transferring 
the organs into a petri dish containing PBS with 2% FCS and gently squeezing them in between 
two 100 µm nylon meshes with bent tweezers. The cell suspension was subsequently 
transferred into a 5 ml tube. Cells were counted and stained with conjugated antibodies on ice 
for 20 min. followed, if applicable, by conjugated Streptavidin staining for 20 min. on ice. For 
intracellular staining, cells fixed and permeabilized using eBioscience transcription factor 
staining buffer set (Invitrogen) and labeled with antibodies on ice for 1 hour. Cells were filtered 
through a 40 µm mesh before acquisition. 
Flow cytometric analysis was performed using BD LSRFortessa or Cytek Aurora while 
cell sorting was done using FACSAria II flow cytometer. The data was analyzed using the 





3.5 Real time quantitative PCR analysis 
Total RNA was isolated from sorted cells with the RNeasy plus micro Kit (Qiagen) 
according to the instructions provided by the manufacturer. cDNA was synthesized using 
SuperScriptIII (Live Technologies) according to manufacturer’s protocol. Real time 
quantitative PCR was carried out using SensiMix SYBR kit (Bioline) on Rotor-Gene 3000A 
(Qiagen). 
Gene Forward Primer Reverse Primer 










G Ccl25 GTTACCAGCACAGGATCAAAT GGAAGTAGAATCTCACAGCA 




Scf AAGGAGATCTGCGGGAATCC CGGCGACATAGTTGAGGGTTA 
Glut4 GTGACTGGAACACTGGTCCTA CCAGCCACGTTGCATTGTAG 
Igf1r GCTTCGTTATCCACGACGATG GAATGGCGGATCTTCACGTAG 
Insr ATGGGCTTCGGGAGAGGAT GGATGTCCATACCAGGGCAC 









3.6 Let-7 isoform quantitative PCR analysis 
RNA was extracted from sorted cells using Let7 Isoform Real-Time qPCR Assay Kit 
according to manufacturer’s manual (BioCat). Real time PCR of miRNAs was done using 
manufacturer’s protocol on Rotor-Gene 3000A (Rotor Gene). 
 






For subcellular localization of transgenic Lin28A, TEC were sorted into IMDM 
containing 10% fetal calf serum, washed with phosphate saline buffer and transferred into µ-
Slides (ibidi). The cells were subsequently fixed and permeabilized using Cytofix/Cytoperm 
(BD Bioscience), washed, blocked with 2% goat serum in perm wash solution and stained with 
FLAG antibody at 4°C overnight.  The next day samples were washed and develop using a 
secondary antibody for 1 hour at room temperature. Vectashield (Vectorlabs) was added to the 
samples and images were acquired using a Leica SP5 confocal (Leica). 
For immunofluorescence analyses, thymi were isolated and immediately frozen in 
optimal cutting temperature compound (OCT) (Cell Path). Sections of 8 μm were prepared on 
a cryostat, dried and fixed with 4% paraformaldehyde (Sigma). The tissue sections were then 
stained with cytokeratin 8 (CK8) and cytokeratin 14 (CK14) antibodies and subsequently 
detected using anti-IgG antibodies conjugated to an Alexa Flour fluorochrome. The images 
were acquired using a Zeiss Axio Imager Z2 scanning microscope (Zeiss).  
 
 
3.8 Cell proliferation analysis using BrdU 
For the detection of TEC proliferation, mice were injected twice intraperitoneally with 
1 mg Bromodeoxyuridine (BrdU, BD Bioscience) within 4 hours. One day later, BrdU 
incorporation was analysed by flow cytometry using the BrdU Flow Kit according to 
manufacturer’s protocol (BD Bioscience).  
 
3.9 Fetal thymic organ cultures 
Thymic lobes were isolated from wild-type animals at embryonic day 14.5 (E14.5) and 
placed on a 0.45 micro pore sized filter (Millipore) floating on IMDM + 10% FCS medium, in 




blocking monoclonal antibody (25 µg/ml, BioLegend) for 8 days at 37°C. Half of the medium 
(with isotype control or PD-L1 blocking antibody) was changed every two days. After 8 days 
of culture, the thymic lobes were digested with PBS containing Collagenase D (1 mg/ml & 
Roche) and 20 µg/ml DNaseI (Roche) at 37°C for 30 min. with occasional pipetting to obtain 
a single cell suspension (it should be noted that fetal thymi, unlike adult thymi, are not digested 




3.10 Reaggregate thymic organ cultures 
Thymic lobes were isolated from 1 – 2 week old wild-type animals and single cell 
suspensions of TEC and thymocytes were obtained using the method described in Section 3.4. 
The cells were stained with fluorescence-tagged antibodies for extracellular antigens and sorted 
to obtain specific cell populations. cTEClo and cTEChi were sorted into separate 1.5 mL 
Eppendorf tubes containing IMDM + 10% FCS. Thereafter, CD69neg CD4CD8pos thymocytes 
were sorted and transferred into the Eppendorf tubes containing the different cTEC subsets in 
a 1:1 ratio. The cells were subsequently spun down, lids opened and the samples were kept for 
48 hours at 37°C in the CO2 incubator. After culturing, the cells were stained with fluorescence-
tagged antibodies and analyzed via flow cytometry. 
 
3.11 SCENITH 
Thymic lobes were harvested from new-born animals and cleaned of remaining fat and 
connective tissue. The lobes were separated and placed into 48 well flat bottom plates (1 lobe 
/ well) containing 250 µl IMDM. Different metabolic inhibitors were added to the appropriate 
wells (250 µl of metabolic inhibitor / well); 2-Deoxy-D-Glucose (2-DG, 400 mM, Sigma 




(2 µM, Abcam)). For the non-treated wells, 250 µl of IMDM was added instead. The samples 
were incubated at 37°C for 40 min. Thereafter, 100 µl of Puromycin (60 µg/ml, Sigma Aldrich) 
was added to each well. The samples were incubated at 37°C for 20 min. The lobes were 
washed with PBS and incubated in 96 well plates containing 250 µl Collagenase D and DNaseI 
at 37°C for 20 min. with occasional pipetting to obtain a single cell suspension. The cell 
numbers were normalized to the lowest cell concentration and the cells stained fluorophore-
conjugated surface antibodies. The samples were subsequently washed with PBS and stained 
with Zombie Dye in PBS. Thereafter, the cells were fixed with Cytofix/Cytoperm Kit (BD 
Bioscience) and intracellular stain performed using anti-puromycin antibody for 1 hour on ice 
before flow cytometric analyses. 
 
3.12 MitoTracker staining 
Thymic lobes were isolated from 4 – 6 week old animals, a single cell suspension of 
TEC prepared and TEC enriched using the method described in Section 3.4. The cell numbers 
were normalized, the cells washed with PBS and resuspended in 1 ml pre-warmed PBS. 
MitoTracker DeepRed was added to the samples (5 nM final concentration, ThermoFisher) and 
the cells were incubated at 37°C for 15 min. The samples were thereafter washed with PBS 
and stained with fluorophore-conjugated antibodies before analysis on the FACS Fortessa.  
 
3.13 TNF-α treatment 
Thymic lobes were isolated from new-born wild-type animals, cut into half and placed 
on a 0.45 micro pore sized filter (Millipore) floating on IMDM + 10% FCS medium, in the 
additional presence of TNF-α (100 ng/ml, R&D systems) or TNF-α plus Ammonium 
pyrrolidinedithiocarbamate (200 µM, Sigma Aldrich) overnight at 37°C. The following day, 




20 µg/ml DNaseI (Roche) at 37°C for 30 min. with occasional pipetting to obtain a single cell 
suspension. The cells were then stained with fluorophore-conjugated surface antibodies. The 
samples were subsequently washed with PBS and stained with Zombie Dye in PBS. Thereafter, 
the cells were fixed with Cytofix/Cytoperm Kit (BD Bioscience) and intracellular stain 
performed using anti cleaved-caspase-3 antibody for 2 hours on ice before flow cytometric 
analyses. 
 
3.14 Statistical analysis 
Results of all experimental data are expressed as mean ± standard deviation (SD). 
Student’s t-test with two tailed distribution and two-sample equal variance parameters was 
calculated using Excel. P-values are indicated in figures are classified in four categories:  
* p ≤ .05, ** p ≤ .01, *** p ≤ .005. p > 0.05 values are considered as not significant. 
3.15 Proteomic analyses 
7575 cTEC and mTEChi were sorted from 4-7 week old Lin28aTEC, Lin28bTEC, 
Lin28axbTEC and control animals into 25 µl of RIPA (ThermoFisher) buffer + 4% NP-40 
(ThermoFisher). The samples were sent to the Discovery Proteomics Facility in Oxford (UK) 
for mass spectrometric analyses using the Liquid chromatography-mass spec/mass spec (LC-
MS/MS) platform. The results were analysed on Perseus Software as previously described 
[115]. Briefly, potential contaminants were first removed before the data set was log-
transformed. Thereafter, annotations were added and missing values replaced from a normal 
distribution. The biological replicates were grouped and the proteins averaged by the median 
in each group. Lastly, scatter plots were generated comparing the different cell types to each 
other. For statistical tests, Student’s t-test with two tailed distribution and two-sample equal 





3.16 Transcriptomic analyses 
22000 cTEChi and 5500 cTEClo were sorted from 2 and 7 week old Lin28aTEC and 
Lin28aCtrl animals. Total RNA was isolated from sorted cells with the RNeasy plus micro Kit 
(Qiagen) according to the instructions provided by the manufacturer. RNA quality control was 
performed with the 5200 fragment analyzer (Agilent) using the high-sensitivity Kit (Agilent).  
The samples were subsequently shipped to GENEWIZ for ultra low input bulk RNA 
sequencing. RNA-seq libraries were generated from total RNA isolated from either cTEChi or 
cTEClo from mice at 2 or 7 weeks of age. RNA libraries were generated using the PE 2x150 
Nexterra mRNA library prep kit (ID) and were sequenced on the Illumina S4 flow cell (2 × 
150). Reads were aligned to the mouse genome (mm10) using STAR aligner (v2.5.1b) [116], 
and transcript abundance was quantified using Salmon (v0.8.2) [117]. Finally, differentially 
expressed genes were identified using DEseq2 (v1.28.1) [118]. RNA deconvolution was 
performed using CIBERSORT [119] with a custom marker gene signature file derived from 
single cell RNA-seq of TEC from ageing mice [47]. Gene set enrichment was performed using 



























4.1 Endogenous Lin28 amounts in TEC decrease during thymus ontogeny and 
correlates with the expression of mature Let-7 isomiRs 
To assess the post-transcriptional regulation of thymic epithelial cell (TEC) 
differentiation, maintenance and function by the Let-7/Lin28 axis, I first analysed the 
expression of Lin28a and Lin28b in wild-type mice during thymus ontogeny. Low numbers of 
Lin28a transcripts were detected in TEC at embryonic day (E) 12.5 but not at later time points 
(Figure 10A, 10B). In contrast, Lin28b transcripts were consistently found at all time points 
tested, albeit most prominent at E12.5 and after birth more abundantly in medullary (m) TEC 
than cortical (c) TEC (Figure 10B). Of the Let-7 family members, transcripts of the isomiRs 
7a, 7b, 7c, 7g and miR-98 but not 7d, 7e, 7f, 7l and miR-202 were detected in TEC of 2 week 
old control mice (Figure 10C). The higher expression of Lin28b in mTEC hereby correlated 



















Figure 10: Endogenous Lin28 and Let-7 expression in TEC of control mice 
(A) TEC gating strategy. Dead cells were excluded with DAPI and forward scatter (FSC-A). TEC 
were identified as CD45 negative but EpCAM and MHCII positive. TEC subsets were phenotyped as 
cTEC (Ly51+UEA-1-) and mTEC (Ly51-UEA1+). Cellular debris was thereafter removed using 
forward scatter (FSC-A) and side scatter (SSC-A) signals which was followed by doublet exclusion 
using SSC height (SSC-H) and width (SSC-W) parameters. (B) Expression of endogenous Lin28a 
and Lin28b in sorted TEC at different time points. Representative data from at least two independent 
experiments analyzing TEC from wild-type animals at embryonic day 12.5 (E12.5), E16.5, new-born 
and 4 weeks of age. qPCR is normalized to Gapdh expression. n.d. = not detectable. (C) 
Quantification of mature Let-7 miRNA expression in sorted TEC subsets. Representative data from 
two independent experiments analyzing control (n = 5) female and male mice at 1-2 weeks of age 






4.2 Transgenic Lin28a and Lin28b expression in TEC inhibits Let-7 maturation  
To investigate the role of Lin28-dependent epigenetic regulation in TEC biology, I 
generated mice with an ectopic expression of either Lin28a or Lin28b targeted to TEC (Figure 
11A). The Lin28 transgenic constructs consisted of a CAG-promoter, a floxed stop codon, a 
Lin28a or Lin28b transgene and were placed into the Rosa26 locus (Figure 11A). The Lin28a 
transgenic construct consisted the Lin28a coding sequence fused to a FLAG-tag, followed by 
an internal ribosomal entry site (IRES), a sequence encoding green fluorescence protein (GFP) 
and woodchuck hepatitis virus post-transcriptional regulatory elements (WPRE) (Figure 11A). 
Mice harboring a Lin28a or Lin28b transgenic construct were crossed to animals expressing 
Cre under the transcriptional control of the TEC specific Foxn1 gene (Figure 11A) [121]. 
Lin28aTEC and Lin28bTEC mice were heterozygous for both Cre and Lin28a or Lin28b, 
respectively, and were compared to Lin28aCtrl and Lin28bCtrl animals which were heterozygous 
for Lin28 transgenes but lacked Cre expression (Figure 11A, 11B, 11C).  
I first analysed the subcellular localization of transgenic Lin28A and Lin28B in 
Lin28aTEC and Lin28bTEC, respectively. Transgenic Lin28A protein was mainly localized to the 
cytoplasm (Figure 11E) whereas transgenic Lin28B protein could not be detected using various 
available detection reagents. Despite the technical difficulties to detect transgenic Lin28B 
protein, both mouse lines and demonstrated a significant and largely comparable reduction or 
complete absence of individual Let-7 isomiRs in both cTEC and mTEC, hence indicating the 
presence of active transgenic Lin28B protein (Figure 11D).  
Thus, the transgenic expression of Lin28 in thymic epithelia reduced the amounts of all 








Figure 11: Transgenic Lin28a and Lin28b expression inhibits Let-7 maturation 
(A) Schematic illustration of Lin28 transgenic constructs. (B) Agarose gel electrophoresis results of 
PCR genotyping for Cre, Lin28a and Lin28b tg from genomic DNA derived from biopsies of wild-
type, Lin28aCtrl, Lin28aTEC, Lin28bCtrl and Lin28bTEC mice. (C) Expression of Lin28a and Lin28b in 
sorted cTEC and mTEC of Lin28aTEC, Lin28bTEC and control mice at 2 weeks of age. qPCR is 
normalized to beta actin expression. (D) Percentage of maximum (max) Let-7 expression in mutant 
TEC relative to control TEC (2-∆Ct of control cTEC and control mTEC set to 100%) in sorted TEC 
subsets of Lin28aTEC (n = 5) and Lin28bTEC (n = 3-4) female and male mice at 2 weeks of age. Let-7d, 
e, f, i and miR-202 were undetectable in cTEC and mTEC. qPCR normalized to u6 expression. (E) 
Immunofluorescence images displaying subcellular localization of transgenic Lin28A in TEC of 
Lin28aTEC and Lin28aCtrl mixed sex mice (n = 3) at 5-6 weeks of age. Images were taken with 63X 
magnification using Leica SP5 confocal microscope. Data is representative of two independent 
experiments. 
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4.3 TEC phenotype of young adult Lin28 mutant animals 
4.3.1 Lin28a and Lin28b tg differentially affect thymus and TEC cellularity 
I next investigated the consequences of constitutive Lin28 expression on thymus organ 
size and stromal organization in young adult animals (i.e. 4-7 week of age). In comparison to 
controls, total thymus cellularity was greatly reduced in Lin28aTEC mice but increased in 
Lin28bTEC animals (Lin28aTEC: 0.82 + 0.26 x 108 vs. Lin28actrl: 2.34 + 0.42 x 108; Lin28bTEC: 
3.2 + 0.83 x 108 vs. Lin28bctrl: 2.51 + 0.61 x 108; Figure 12A, 12B). The thymus of Lin28aTEC 
and Lin28bTEC mice displayed a normal segregation into individual cortical (CK8+CK14-) and 
medullary (CK8-CK14+) compartments with distinct junctions separating the two (Figure 12C).   
TEC are positively identified by their expression of the cell surface markers MHCII and 
EpCAM and their lack of expression of the hematopoietic marker CD45 (CD45- MHCII+ 
EpCAM+). The frequency of TEC was unaltered while TEC cellularity correlated with total 
thymus cellularity in all mutant mouse strains (Figure 12D, 12E). To determine the epistatic 
relationship between Lin28a and Lin28b transgenes, I crossed Lin28aTEC and Lin28bTEC mice 
to generate Lin28axbTEC animals. Both total and TEC absolute numbers were reduced in these 
triple-transgenic animals comparable to that observed for Lin28aTEC mice and thus revealing a 
dominant effect of Lin28a over Lin28b (Figure 12D, 12E).  To test whether the dominant effect 
of Lin28a was due to a down-modulation of Lin28b expression in Lin28axbTEC mice, I analyzed 
the expression of Lin28a and Lin28b in these animals. Both, Lin28a and Lin28b were over-
expressed in cTEC and mTEC of Lin28axbTEC mice when compared to control cells of the same 
phenotype, hence excluding a negative effect of Lin28a on the expression of Lin28b (Figure 
12F). 
I then analysed the impact of transgenic Lin28 expression on the differentiation and 
maintenance of individual, flow cytometry defined TEC subsets. cTEC are classified by their 




(Ly51+UEA1-) while mTEC bind to UEA-1 and are Ly51 negative (Ly51-UEA1+). I found that 
the cTEC:mTEC ratio was increased in Lin28aTEC and Lin28axbTEC mice in comparison to age-
matched controls (Figure 12G, 12H). In contrast, Lin28bTEC mice showed a cTEC:mTEC ratio 
that was unchanged compared to control, albeit the cellularity of both subpopulations had 
increased as a result of a larger thymus size (Figure 12H, Figure 12I).   
I then undertook a detailed analysis of cTEC and mTEC differentiation. To this end, 
cTEC and mTEC were further subdivided according to their expression of MHCII and Sca-1. 
In young adult mice cTEC progress from immature cTEC (designated cTEClo and defined as 
MHCIIlo Sca-1pos) to mature cTEC (designated cTEChi and defined as MHCIIhi Sca-1lo) while 
mTEC differentiate from an immature mTEC (designated mTEClo; defined as MHCIIlo Sca-1hi) 
stage to mature mTEC (designated mTEChi and defined as MHCIIhi Sca-1int) before becoming 
terminally mature mTEC (tm mTEC and defined as MHCIIlo Sca-1lo). The frequency of 
immature cTEClo was 4-5 fold lower while the relative and absolute cellularity of mature 
cTEChi was increased in Lin28aTEC and Lin28axbTEC mice when compared to controls (Figure 
12G, 12J, 12K). In contrast, maturational progression from an immature to a mature cTEC 
phenotype appeared to be unaffected in Lin28bTEC mice (Figure 12G, 12J, 12K). Changes in 
mTEC differentiation consequent to the constitutive Lin28 expression were uniform for all 
transgenic mice in that the frequency of immature mTEClo was reduced whereas tm mTEC were 
more abundant (Figure 12G, 12J, 12K). Concurrently, relative numbers of phenotypically 
mature mTEChi had also increased, although statistical significance was only observed for mice 
that expressed the Lin28a transgene either alone or together with Lin28b transgene (Figure 12G, 
12J, 12K).  
Thus, cTEC and mTEC numbers and subset composition were differentially affected in 





















Figure 12: Lin28a and Lin28b tg differentially affect thymus and TEC cellularity  
(A) Thymus cellularity of female mice, at 4-7 weeks of age. Data are pooled from multiple 
experiments, analyzing Lin28aCtrl (i.e. Lin28a-) (n = 26), Lin28aTEC (i.e. Lin28a+) (n = 33), Lin28bCtrl 
(i.e. Lin28b-) (n = 21), Lin28bTEC (Lin28b+) (n = 24), Lin28axbCtrl (i.e. Lin28axb-) (n = 17) and 
Lin28axbTEC (Lin28axb+) (n = 8) animals. (B) Representative images of thymi from 5 week old 
Lin28aTEC and Lin28aCtrl female mice and 14 week old Lin28bCtrl and Lin28bTEC female animals. Data 
is taken from my Master Thesis. (C) Representative immunofluorescence images of thymic sections 
from 4-6 week control, Lin28aTEC, Lin28bTEC and Lin28axbTEC female mice (n = 3) at 4-6 weeks of 
age. Antibodies specific for cytokeratin 8 (CK8) were used for the detection of cTEC and cytokeratin 
14 (CK14) for the identification of mTEC. Data is representative of two independent experiments. 
Images were taken with 10X magnification using Zeiss Axio Imager Z2 scanning microscope. (D) 
Relative and (E) absolute TEC numbers. (F) Expression of Lin28a and Lin28b in sorted cTEC and 
mTEC of Lin28axbTEC and control mice at 2 weeks of age. qPCR is normalized to beta actin 
expression. (G) Representative flow cytometry plots detailing cTEC and mTEC composition based on 
Ly51 expression and reactivity for UEA-1 (i) and cTEC and mTEC subpopulations based on MHCII 
and Sca-1 expression (ii). (H) cTEC:mTEC ratio. (I) cTEC and mTEC absolute numbers. (J) 
Frequencies of cTEClo, cTEChi and mTEClo, mTEChi, terminally mature (i.e. tm) mTEC within cTEC 
and mTEC, respectively. (K) Absolute number of cTEChi, cTEClo and mTEClo, mTEChi, tm mTEC. 
For experiments (D) – (E) and (G) – (K) female mice, at 4 weeks of age were used. Data are 







4.3.2 Ectopic expression of Lin28a tg increases TEC proliferation and apoptosis 
Lin28a is known to increase cell proliferation and reduce cell survival [100, 122]. Hence, 
I next assessed whether the Lin28a tg induced changes in the TEC compartment were due to 
alterations in TEC proliferation or apoptosis. Using BrdU pulse/chase experiments I found that 
cTEChi of Lin28aTEC mice displayed an increased frequency of proliferating (BrdU positive) 
cells (Lin28aTEC: 27.3 + 5.6 % vs. Lin28aCtrl: 15.2 + 3.3 %) while cTEClo and all mTEC 
subpopulations showed comparable BrdU incorporation to control (Figure 13A, 13B).  
In contrast, cTEClo and mTEC were more prone to apoptosis, as they contained increased 
frequencies of cells with cleaved, activated caspase-3 identifying committed apoptotic cells 
(Figure 13C, 13D). To investigate whether these differences were the result of an increased 
availability of Caspase-3 in Lin28a mutant cells, I next stained for total Caspase-3 (i.e. cleaved 
plus non-cleaved Caspase-3). Lin28a mutant and control TEC showed similar expression of 
total Caspase-3 as determined by geometric mean fluorescence intensity (gMFI), indicating that 
the survival defect seen in these cells was due to an increased ratio of activated caspase-3/total 
caspase-3.  
No differences in TEC proliferation and apoptosis were found in Lin28bTEC animals 
(Figure 13B, 13D, 13E). Hence, these results suggest that the increased cTEChi cellularity in 
Lin28aTEC was due to their increased proliferative capacity while the reduction in cTEClo and 
















4.4 Thymocyte development in young adult Lin28 transgenic mice 
4.4.1 Thymus settling is differentially affected by Lin28a and Lin28b 
As thymocyte cellularity and thus thymic size linearly correlate to the number of early 
thymic progenitors (ETP) [123], we I next investigated the quantity of T cell progenitors in a 
microenvironment containing Lin28a and/or Lin28b over-expressing epithelia. Defined as NK 
cell, B cell, erythroid and myeloid lineage negative (Lin-) and CD117(ckit)+CD44+CD25- cells, 
ETP were significantly reduced in mice expressing Lin28a tg whereas Lin28bTEC mice 
displayed an increase in ETP cellularity when compared to control (Figure 14A, 14B).  
Thymus settling is orchestrated by a set of well-defined chemokines expressed in TEC, 
namely CC-chemokine ligand 21 (Ccl21), Ccl19, Ccl25 and CXC-motif-chemokine 12 
(Cxcl12) [52]. Moreover, the survival and proliferation of the most immature thymocytes are 
controlled by Interleukin-7 (Il-7) and stem cell factor (Scf) [54, 55, 57, 58]. Investigating the 
transcript numbers of these chemokines using qPCR, I found that in TEC of Lin28aTEC mice 
the expression of Ccl21 was reduced by 3-fold, Ccl19 levels decreased while the expression of 
Ccl25 and Cxcl12 increased when compared to control TEC (Figure 14C). The expression of 
factors that promote the survival and proliferation of these early thymic immigrants, namely Il-
7 and Scf, were significantly increased in TEC that express Lin28a transgene (Figure 14D). 
In Lin28b tg TEC, the expression of Ccl21 was slightly reduced, Ccl19 and Cxcl12 levels 
unchanged whereas the number of Ccl25 transcripts was significantly increased compared to 
Figure 13: Ectopic expression of Lin28a tg increases TEC proliferation and apoptosis  
(A) Representative gating strategy and (B) quantitative analysis of BrdU positive TEC subsets 24 hours 
after BrdU administration. (C) Representative gating strategy and (D) relative numbers of activated 
Caspase-3 positive cTEClo, cTEChi and mTEClo, mTEChi, tm mTEC. (E) Geometric mean fluorescence 
intensity (gMFI) of Total Caspase-3. Data is representative of three independent experiments analyzing 







TEC of Lin28bTEC mice (Figure 14C). Moreover, the expression of Il-7 was reduced while Scf 
transcript numbers increased upon Lin28b transgenic expression (Figure 14D). 
As TEC numbers are severely reduced in Lin28a mutant mice, this data suggests that the 
lower expression of Ccl21 and Ccl19 in these cells may have caused a drop in ETP attraction 
and subsequent thymic hypoplasia. The increased expression of Il-7 and Scf in Lin28a tg mice 
indicates that the survival of these early thymic immigrants is unaltered in these animals. In 
Lin28b mutant mice however, increased TEC numbers, producing more Ccl25 and regular 
amounts of Cxcl12 and Ccl19 may compensate the slight reduction in Ccl21 and cause increased 
ETP attraction and subsequent enlargement of the thymus. In Lin28bTEC mice, the increased 
numbers of TEC expressing more Scf might balance the reduced expression of Il-7 and induce 
regular maintenance of ETP. 
Figure 14: Thymus settling is differentially regulated by Lin28a and Lin28b 
(A) Gating strategy for ETP thymocytes: live singlets, defined by FSC and SSC parameters and DAPI 
exclusion, were successively depleted of CD4pos, Lineagepos, CD8posCD24lo and CD44pos CD117neg 
cells. (B) ETP cellularity. Data is representative of at least two independent experiments analyzing 
Lin28aTEC, Lin28bTEC, Lin28axbTEC and control female mice at 4-7 weeks of age. (C) Expression of 
chemokines important for ETP attraction in sorted TEC. (D) Expression of survival factors for ETP in 
TEC. Data is representative of at least two independent experiments analyzing Lin28aTEC, Lin28bTEC 
and control female mice at 6-7 weeks of age. qPCR normalized to bACT expression. * p < .05, ** p < 







4.4.2 Initial stages of thymocyte maturation are unaffected in Lin28 mutant mice 
I next investigated whether the changes in the epithelial compartment of young adult 
Lin28aTEC, Lin28bTEC and Lin28axbTEC mice affected thymocyte differentiation. Thymus size 
is determined by the numbers of CD4+CD8+ double positive (DP) thymocytes that make up 
approximately 80% of the thymic cell mass in the steady state. DP cells originate from CD4-
CD8- double negative (DN) cells that undergo a proliferative burst after successful 
rearrangement of their TCRβ chain (beta selection checkpoint). Early thymocyte differentiation 
proceeded normally in all three mutant strains demonstrated by comparable proportions of pre-
DP maturational subsets both before (DN1 [CD44+CD25-], DN2 [CD44+ CD25+], DN3a 
[CD44- CD25+ CD71-]) and after the TCR beta selection checkpoint (DN3b [CD44-CD25lo 
CD71+], DN4 [CD44- CD25- CD71+], CD8 ISP [CD4- CD8+ CD71+ immature single positive]; 
Figure 15A, 15B). Hence, a developmental block in thymocyte differentiation (Lin28aTEC and 
Lin28axbTEC) or accelerated transitions (Lin28bTEC) at the pre-DP stage could be ruled out as 






4.4.3 Thymocyte positive selection is compromised in Lin28aTEC and Lin28axbTEC mice 
Next, I analyzed whether subsequent thymocyte developmental stages were affected in 
Lin28 mutant animals. Thymocyte maturation after the CD8 ISP stage involves the 
upregulation of CD4 and the productive rearrangement of the TCRα chain to express a TCRα/ 
TCRβ complex on the surface. DP thymocytes that generated a TCR with intermediate avidity 
to MHC:peptide complexes receive a survival signal and continue their maturation [63]. This 
process, known as positive selection, rescues thymocytes from undergoing programmed cell 
death and initiates differentiation into the CD4 or CD8 lineage [4, 61]. However, only a small 
fraction of DP cells will encounter a signal with intermediate avidity and continue with their 
development. DP cells expressing MHC II restricted TCR down-regulate CD8 surface 
expression to become CD4 single positive (SP) while MHC I binding by TCR promotes CD4 
down-modulation and subsequent maturation into CD8 SP [124]. The frequencies of CD4 and 
CD8 SP thymocytes was decreased whereas that of DP cells increased in mice where Lin28a 
was constitutively expressed in TEC (Figure 16A). However, the DP gate displayed in Figure 
16A also contains SP committed thymocytes that are “masked” as DP due to their complex 
maturational progression. Hence, I applied a more sophisticated gating strategy to reveal those 
SP committed thymocytes hiding behind a DP mask and to calculate the frequencies of DP and 
SP thymocytes in mutant and control animals (Figure 16B). Indeed, the relative numbers of 
CD4 and CD8 SP were reduced and that of DP cells increased in mice that express Lin28a 
transgene (Figure 16C). 
Figure 15: Initial stages of thymocyte maturation are unaffected in Lin28 mutant mice 
(A) Representative gating of preDP thymocytes. (B) Quantitative analysis of developmental stages 
within pre-DP thymocytes in Lin28aTEC, Lin28bTEC and Lin28axbTEC animals. Female mice at 4-6 
weeks of age were used, Creneg controls for Lin28axbTEC consisted of single transgenic Lin28aCtrl and 
Lin28bCtrl animals. Data are representative of at least two independent experiments. * p < .05, ** p < 





I next analysed the efficacy of positive thymocyte selection in all three Lin28 transgenic 
mouse lines. DP thymocytes that have received a positive selection signal are marked by the 
surface expression of the early activation marker CD69 [125]. The frequencies of TCRpos DP 
thymocytes that have increased their TCR surface amounts and express CD69 were comparable 
in all animals. (Figure 16D).  However, up-regulation of CD69 and TCR surface expression 
occur gradually, hence it is challenging to define clear boundaries to separate non-selected DP 
from those having received positive selection signals. Thymocytes also down-regulate the 
expression of the two co-receptors CD4 and CD8 upon positive selection (dulling) [67]. Hence, 
I utilized co-receptor dulling as an additional criterion to unequivocally identify positively 
selected cells. To compare for background levels, boundaries for DPdull gating were set first on 
pre-selection CD69neg thymocytes and, as expected, the frequencies of cells residing within the 
DPdull gate did not differ between mutant and control animals (Figure 16E). However, I 
detected a significant decrease of DPdull cells within the CD69pos population in animals 
harbouring the Lin28a transgene suggestive of fewer DP undergoing positive selection (Figure 
16E). As an independent means to rule out putative biases in defining DPdull gates, I calculated 
the reduction of co-receptor gMFI in total CD69pos thymocytes in relation to the gMFI of their 
CD69neg counterparts. Compared to controls, CD69pos cells from Lin28aTEC and Lin28axbTEC, 
but not Lin28bTEC mice had higher co-receptor gMFIs (Figure 16F), thus corroborating a 
Lin28a tg cTEC insufficiency in mediating positive selection. Consequently, phenotypically 










Figure 16: Thymocyte positive selection is compromised in Lin28aTEC and Lin28axbTEC animals 
(A) Representative plots displaying frequencies of DP, CD4 and CD8SP in Lin28aTEC and control 
animals. (Bi) Representative gating strategy for DP thymocytes: DP cells were identified as 
CD4posCD8pos and were depleted of CCR7posTCRhi (=medullary) cells. (Bii) Gating strategy for TCR
pos 
thymocytes and SP cells: TCRneg cells were excluded from live singlets and CD4SP cells were gated 
for high TCR expression. CD8SP were identified as TCRhi cells depleted of CCR7neg (=cortical) CD4pos 









4.4.4 Late stages of SP thymocyte maturation are altered by Lin28a tg 
Next, I studied the maturational progression within SP thymocytes. The differentiation 
of CD4 SP thymocytes can be split into three developmental stages using the differential cell 
surface expression of CCR7, CD24 and CD69 [70]. The earliest CD4 SP thymocytes 
(designated SM) are CD24 positive, reside in the cortex and are CCR7 negative. Upon up-
regulation of CCR7 they gain the capacity to migrate into the medulla [59] where they display 
increased CD69 expression and gain the competence to proliferate (designated M1) before 
down-regulating CD69 and CD24 to become fully mature cells (designated M2) that are 
equipped to produce cytokines and are ready to exit the thymus. However, CD4 SP thymocytes 
can also develop into regulatory T-cells. This developmental pathway requires TCR avidities 
which are at the border between positive and negative selection and is marked by the expression 
of the transcription factor forkhead box P3 (FoxP3) [126]. CD8 SP differentiate in the medulla 
where they first adopt a CD69+CD24+ (M1) phenotype before down-modulating the surface 
expression of these markers to become M2 cells, competent to emigrate. Analyzing the 
frequency of these thymocyte subsets in Lin28 mutant mice I found that the frequency of SM 
Initial gates used for defining the CD4 and CD8 lineage were pasted back into the SP subsets to 
illustrate the cells’ location. (C) Quantitative analysis of preDP, DP, CD4 and CD8SP within 
thymocytes in mutant Lin28aTEC, Lin28bTEC, Lin28axbTEC and control animals. (Di) Representative 
gating strategy for TCRpos DP thymocytes before and after positive selection: DP cells were gated for 
TCR expression and depleted of CCR7pos (=medullary) HeliosposPD1pos (=negatively selected) cells. 
Pre-positive selection DP were identified as CD69negTCRpos while post-positive selection DP gated as 
CD69posTCRhi cells. (Dii) Quantitative analysis of TCR
pos DP thymocytes before (CD69neg) and after 
(CD69pos) positive selection. (E) Identification of co-receptor dulling in TCRpos DP thymocytes before 
(DP CD69neg) and after (DP CD69pos) positive selection. (F) Geometric mean fluorescence intensity 
(gMFI) of co-receptors CD4 and CD8 in CCR7neg (=cortical) TCRpos DP thymocytes expressing CD69 
compared to CD69neg cells (arbitrarily set as 1). Female mice at 4-6 weeks of age were used, Creneg 
controls for Lin28axbTEC consisted of single transgenic Lin28aCtrl and Lin28bCtrl animals. Data are 








in the CD4 lineage was increased while the relative numbers of M2 in CD4SP and CD8SP was 
decreased in Lin28aTEC and Lin28axbTEC animals (Figure 17A, 17B). Furthermore, frequencies 
of Foxp3+ Treg within CD4SP were reduced by 30 - 50% in mice where Lin28a was 
constitutively expressed (Figure 17C). Taken together, the enforced expression of Lin28a in 
TEC compromised the cells’ capacity to terminally differentiate thymocytes and provide 





Figure 17: Late stages of SP thymocyte maturation are altered by Lin28a tg 
(A) Representative plots and quantitative analysis of CCR7neg (=cortical) semi-mature (SM) and 
CCR7pos (=medullary) mature (M, divided into M1 and M2 according to CD69 and CD24 expression) 
subsets in Foxp3neg (=excluding Treg) CD4SP. (B) Representative plots and quantification of CD8SP 
M1 and M2 populations.  (C) Frequencies of Foxp3pos Treg in CD4SP. Female mice at 4-6 weeks of age 
were used, Creneg controls for Lin28axbTEC consisted of single transgenic Lin28aCtrl and Lin28bCtrl 
animals. Data are representative of at least two independent experiments. * p < .05, ** p < .01, *** p 







4.4.5 Lin28a tg cTEC are limited in their capacity to induce thymocyte negative selection 
As the frequency of mature SP thymocytes is also influenced by the extent of negative 
selection, I quantified negatively selected thymocytes. Thymocytes undergoing negative 
selection in the cortex are marked by high co-expression of Helios and PD-1 among CCR7-
Foxp3- TCR+ DP and CD4SP cells (wave 1 negative selection). In the medulla, negatively 
selected cells are identified by the expression of Helios within the CCR7+ FoxP3- CD4SP cells 
(wave 2 negative selection) [72]. 
  Lin28aTEC and Lin28axbTEC displayed a 40-50% reduction in the frequency of 
negatively selected cortical thymocytes when compared to Lin28bTEC or control mice (Figure 
18A). In contrast, negative selection of medullary thymocytes was unaffected in all Lin28 
transgenic animals (Figure 18B). Taken together, these data demonstrate that enforced Lin28A 
expression in TEC dominantly interferes with cortical positive and negative selection, reduces 
the number of thymic Treg and affects developmental progression of SP in the medulla to a 

























Figure 18: Lin28a tg cTEC are limited in their capacity to induce thymocyte negative selection 
(A) Gating strategy and quantification of negatively selected CCR7neg (=cortical), FoxP3neg 
(=excluding Treg) CD4 lineage thymocytes expressing Helios and PD-1
pos (wave 1 negative selection).  
(B) Gating strategy and relative numbers of medullary Heliospos CD4SP undergoing negative selection 
(wave 2 negative selection). Female mice at 4-6 weeks of age were used, Creneg controls for 
Lin28axbTEC consisted of single transgenic Lin28aCtrl and Lin28bCtrl animals. Data are representative of 









4.5 Thymus phenotype of juvenile Lin28aTEC animals 
4.5.1 Juvenile Lin28aTEC mice have a regular cTEC but altered mTEC subset composition 
Because of the interesting phenotype imposed by Lin28a tg, I analysed in the next 
experiments Lin28aTEC animals. I hypothesized that the defects in T cell maturation in young 
adult Lin28aTEC animals were due to the changes in their TEC subset composition. Upon closer 
inspection, the phenotype of Lin28a tg cTEC resembled that of neonatal wild-type cTEC 
(Figure 19A) [127]. I therefore compared juvenile Lin28aTEC mice to age matched controls 
and, contrary to young adult adults, 2 week old Lin28aTEC mice displayed unchanged thymus 
cellularity (Figure 19B). Only after this time point I found a significant reduction in thymus 
size caused by Lin28a tg expression (Figure 19B). Thus, I decided to probe whether the changes 
in absolute TEC numbers, TEC subset composition, ETP attraction and thymocyte 
development are also apparent in juvenile Lin28aTEC mice. Total TEC, cTEC and mTEC 
cellularities were comparable between mutant and control animals at juvenile age (Figure 19C, 
19D, 19E, 19F). While the composition of cTEC was normal, I found small differences in 
mTEC subset composition with mTEClo being mildly under-represented in Lin28aTEC mice at 
2 weeks of age (Figure 19G, 19H). While the transcripts of Ccl21, Ccl19 and Cxcl12 were 
significantly reduced, transcript numbers of Ccl25 are significantly higher in mTEC of juvenile 
Lin28aTEC mice. Furthermore, the expression of Il-7 expression was unchanged and the amount 
of Scf transcripts increased in Lin28aTEC animals at 2 weeks of age (Figure 19I). 
Thymus organ size correlated with an unchanged cTEC compartment in juvenile 
Lin28aTEC mice. As the expression of chemokines and survival factors for ETP was similarly 
affected in juvenile Lin28a mutant mice as in young adult Lin28aTEC animals, this data suggests 
that cTEChi and cTEClo differentially regulate thymic settling, explaining the changes in thymus 




already display some of the changes found in the mTEC compartment of young adult mutant 
animals.  
Figure 19: Juvenile Lin28aTEC mice have regular cTEC but altered mTEC subset composition 
(A) Representative Sca-1 and MHCII expression in cTEC of 2 week old (=juvenile) and 4 week old 
(=young adult) Lin28aTEC and control female animals. Data are representative of at least two 
independent experiments. (B) Thymus cellularity in Lin28aTEC and controls between 2 and 6 weeks of 
age.  Apart from 3-week time point (one experiment, n = 3, mixed sex mice), data are pooled from at 
least two independent experiments analyzing female and male mice (n = 4 – 18) at the indicated ages. 
(C) Relative and (D) absolute TEC numbers. (E) cTEC:mTEC ratio. (F) Absolute numbers of cTEC 






4.5.2 Cortical selection proceeds normally while medullary thymocyte maturation is 
compromised in juvenile Lin28aTEC animals 
Next, I investigated thymopoiesis in juvenile mice. Early thymocyte development was 
unaltered as the frequencies of pre-DP thymocyte subpopulations prior to and post TCR beta 
selection were comparable between mutant Lin28aTEC and control littermates (Figure 20A). 
The relative numbers of CD4 and CD8 SP thymocyte were unchanged suggesting that 
thymocyte positive and negative selection are unaffected by ectopic Lin28a expression early 
in life (Figure 20B). The percentage of DPdull and the gMFI of CD4 and CD8 co-receptors 
within the CD69pos population in Lin28aTEC mice were similar to those of control, confirming 
that positive selection of thymocytes proceeded normally (Figure 20C, 20D, 20E). In addition, 
I found no changes in the frequencies of thymocytes undergoing negative selection in the cortex 
as well as in the medulla (Figure 20F, 20G). However, late stages in the maturation of SP 
thymocytes were affected as I detected fewer M2 cells in both CD4 and CD8 lineages (Figure 
20H, 20I). Furthermore, the percentage of regulatory thymocytes was reduced in Lin28aTEC 
mice (Lin28aTEC: 2.2 + 0.1 % vs. Lin28aCtrl: 3.1 + 0.5 %; Figure 20J). Hence, while Lin28aTEC 
showed normal thymocyte positive and negative selection in juvenile mice, the ectopic 
expression of Lin28a caused a reduction of mature SP and FoxP3+ regulatory thymocytes.  
independent experiments. (B) Thymus cellularity in Lin28aTEC and controls between 2 and 6 weeks of 
age.  Apart from 3-week time point (one experiment, n = 3, mixed sex mice), data are pooled from at 
least two independent experiments analyzing female and male mice (n = 4 – 18) at the indicated ages. 
(C) Relative and (D) absolute TEC numbers. (E) cTEC:mTEC ratio. (F) Absolute numbers of cTEC 
and mTEC. (G) Frequency and (H) absolute number of cTEClo, cTEChi and mTEClo, mTEChi, tm 
mTEC. (I) Expression of chemokines important for ETP attraction and survival factors for ETP in 
sorted cTEC and mTEC. For experiments (C – I), data are representative of at least two independent 
experiments analyzing Lin28a mutant and control female mice at 2 weeks of age. * p < .05, ** p < .01, 






Together, these results show that thymus cellularity, cTEC subset composition, as well 
as thymocyte positive and cortical negative selection are unaffected in 2 week old Lin28aTEC 
animals. At this time point the cTEC compartment is mainly composed of cTEChi, indicating 
that cTEChi and cTEClo have distinct roles in controlling thymus seeding and regulating 
thymocyte positive and negative selection. However, transgenic Lin28a expression in TEC of 
juvenile mice affects the composition of the mTEC compartment, correlating with the 
alterations in medullary thymocyte development found in these mice. 
Figure 20: Cortical selection proceeds normally while medullary thymocyte maturation is 
compromised in juvenile Lin28aTEC animals 
(A) Frequencies of developmental stages within pre-DP thymocytes in mutant Lin28aTEC and control 
mice. (B) Relative numbers of preDP, DP, CD4 and CD8SP within thymocytes. (C) Frequencies of 
TCRpos DP after (CD69pos) positive selection. (D) Quantitative analysis of co-receptor dulling of 
CD69neg and CD69pos within TCRpos DP thymocytes. (E) gMFI of CD4 and CD8 co-receptors in 
CCR7neg TCRpos DP thymocytes expressing CD69 compared to CD69neg cells (arbitrarily set as 1). (F) 





















mice. (B) Relative numbers of preDP, DP, CD4 and CD8SP within thymocytes. (C) Frequencies of 
TCRpos DP after (CD69pos) positive selection. (D) Quantitative analysis of co-receptor dulling of 
CD69neg and CD69pos within TCRpos DP thymocytes. (E) gMFI of CD4 and CD8 co-receptors in 
CCR7neg TCRpos DP thymocytes expressing CD69 compared to CD69neg cells (arbitrarily set as 1). (F) 
Quantitative analysis of cortical CCR7neg (=cortical) CD4 lineage thymocytes expressing Helios and 
PD1 (wave 1 negative selection). (G) Frequency of medullary Heliospos CD4SP undergoing negative 
selection (wave 2 negative selection). (H) Relative numbers of SM, M1 and M2 in FoxP3neg (=exclude 
Treg) CD4SP. (I) Quantification of M1 and M2 thymocytes in CD8SP. (J) Frequency of FoxP3
pos Treg 
in CD4SP. Data are representative of at least two independent experiments analyzing Lin28a mutant 







4.6 cTEClo and cTEChi possess distinct positive selection potentials 
 To identify mechanisms that account for the observed defects in thymocyte selection 
by Lin28a transgenesis in young adult mice, I next analysed the TEC compartment of Lin28a 
mutant animals in more detail. While juvenile mutant mice had unchanged frequency of cTEC 
that express the inhibitory programmed death-ligand 1 (PD-L1), a cell surface molecule known 
to inhibit TCR-mediated positive selection of CD4+ thymocytes [128], young adult Lin28aTEC 
mice displayed an increased frequency of PD-L1 positive cTEC when compared to age 
matched controls (Juvenile: Lin28aTEC: 90.9 + 2.2 % vs. Lin28aCtrl: 82.2 + 5.8 %; Young adult: 
Lin28aTEC: 77.5 + 4.6 % vs. Lin28aCtrl: 31 + 5.2 %, Figure 21A). Blocking PD-L1 in wild type 
fetal thymic organ cultures (FTOC) increased the generation of CD4 SP thymocytes (anti-PD-
L1: 12.5 + 1.5 vs. isotype: 10.2 + 1.6 vs. untreated: 11 + 0.8; Figure 21B). Because PD-L1 is 
differentially expressed between cTEChi and cTEClo (53.3 + 5.6 % vs. 9.3 + 2.8 %; Figure 21C) 
I next probed wild-type cTEClo and cTEChi separately for their capacity to mediate positive 
selection. To this end, I performed reaggregate thymic organ culture (RTOC) experiments and 
cultured CD69neg DP thymocytes for 48h with either cTEClo and cTEChi and analysed the 
upregulation of CD69 (Figure 21D, 21E). I could demonstrate that cTEClo were more effective 
in positive selection of thymocytes (as identified CD69pos, CD4CD8dull) when compared to 
cTEChi (15 + 1.3% vs. 10 + 0.6%; Figure 21F).  
 Hence, reduced positive selection in young adult Lin28aTEC can in part be explained by 







Figure 21: cTEClo and cTEChi possess distinct selection potentials 
(A) Representative contour plots detailing PD-L1 expression in cTEC and quantitative analysis of PD-
L1pos cTEC. Data is representative of at least two independent experiments analyzing Lin28aTEC and 
control mice at 2 (=juvenile mice) and 4 (=young adult) weeks of age. (B) Gating strategy and  























Thymic lobes for FTOC were isolated from wild-type animals at embryonic day 14.5 (E14.5) and 
cultured in medium only, in the presence of isotype control or PD-L1 blocking antibody for 8 days. 
Data is representative of three independent experiments. (C) Representative flow cytometry histograms 
detailing PD-L1 expression in cTEChi and cTEClo of 4 week old Lin28aCtrl mice. (D) Flow cytometry 
sorting strategy and sort purity of CD69neg DP thymocytes (i.e. pre-positive selection DP). (E) Gating 
strategy and purity of isolated cTEChi and cTEClo. (F) Relative numbers of thymocytes that received a 
positive selection signal from cTEChi or cTEClo based on CD69 upregulation and co-receptor dulling 
after 48 hours of culture. CD69neg thymocytes were sorted and reaggregated with either cTEClo or 
cTEChi for 48 hours (n = 4-8). (D) – (F) Cells were sorted from mixed sex wild-type animals at 1-2 
weeks of age. Data is representative of two independent experiments analyzing reaggregate thymic 





4.7 Transcriptomic analyses of cTEClo and cTEChi from juvenile and young 
adult Lin28aTEC mice  
4.7.1 Lin28a over-expression changes the TEC subtype composition at juvenile and adult age 
I performed RNA-seq to identify in a non-supervised fashion the transcriptomic 
changes that relate to the numerical, phenotypic and functional changes of cTEClo and cTEChi 
in juvenile and young adult Lin28aTEC mice. I first performed a principal component analysis 
(PCA) to assess the variability of the samples. I found that the cTEClo and cTEChi samples 
from each mouse genotype and each time point clustered together in the PCA diagram (Figure 
22A). As expected, the Lin28a transgenic samples showed higher expression of Lin28a 
compared to control samples of the same phenotype and age (Figure 22B).  
Because Lin28a over-expression lead to a near complete loss of cTEClo in young adult 
animals (Figure 12J), I analysed the effect of Lin28a tg on the abundance of transcriptomically 
specified TEC subtypes that were identified within flow cytometric defined cTEC at the single 
cell level [47]. For clarifications, hereafter I refer to cytometrically defined TEC as subsets and 
transcriptomically identified TEC as clusters.  
To infer the composition of cTEClo and cTEChi from juvenile and young adult 
Lin28aTEC animals I deconvoluted our bulk RNA sequencing data by using the marker genes 
for clusters identified recently [47]. This analysis revealed that cTEClo of 2 week old Lin28aTEC 
mice had an increased signature of mature cTEC and proliferating TEC and showed a reduced 
signal from intertypical TEC than control (Figure 22C). At 7 weeks of age, intertypical TEC 
dominated the cTEClo that express Lin28a tg (Figure 22C).  Intertypical TEC are a TEC cluster 
which are part of cytometrically defined cTEC as well as mTEC and are believed to be derived 
from a cTEC like progenitor (i.e. expressing β5t) that have the potential to develop into the 




that their contribution to the mTEC lineage increases with age [47]. Hence this result suggests, 
that early in life Lin28a tg expression increases the pool of proliferating and mature cTEC 
while at adult age blocks the further maturation of intertypical TEC into mTEC, leading to their 
over-representation within the cytometrically defined cTEClo compartment. This result is also 
in line with our data from young adult mice showing that the relative and absolute mTEC 
numbers are reduced upon Lin28a ectopic expression (Figure 12H, 12I).  
Within the cTEChi subset of 2 week old Lin28aTEC, I found an over-representation of 
the perinatal cTEC cluster (Figure 22C). Perinatal cTEC are a TEC cluster which are part of 
cytometrically identified cTEC that are most abundant in young mice and are thought to 
represent progenitor cells early in life. At 7 weeks of age Lin28a over-expression lead to a 
strong mature cTEC signature and a reduced intertypical signal (Figure 22C). Together, this 
result implies that Lin28a tg increases the cTEC progenitor pool at juvenile age and later in life 
















4.7.2 The impact of Lin28a tg on the transcriptome of cTEC increases with age 
I next analyzed the differentially expressed genes in cTEClo and cTEChi of 2 week and 
7 week old Lin28aTEC. At 2 weeks of age, ectopic Lin28a expression caused 355 genes to be 
differentially expressed in cTEClo whereas 2437 genes were differentially regulated in Lin28a 
tg cTEChi (Figure 23A). In 7 week old Lin28aTEC animals, 1896 differentially expressed genes 
were found in cTEClo while 4096 genes were differentially regulated in cTEChi (Figure 23A). 
Hence, this data suggests that Lin28a tg has a bigger effect on the transcriptome of cTEChi than 
cTEClo and that the impact of Lin28a over-expression on the gene expression profile of cTEC 
Figure 22: Lin28a over-expression changes the TEC subtype composition at juvenile and adult age 
(A) Principal component analysis (PCA) of samples from RNA sequencing of cTEClo and cTEChi of 2 
and 7 week old Lin28aTEC and Lin28aCtrl animals. PC1 separates cTEClo from cTEChi and PC2 
corresponds to the Lin28aCtrl / Lin28aTEC axis. (B) Quality control of Lin28a expression in control and 
Lin28a tg samples. (C) Estimated composition of each data type based on the subsets defined in [47]. 
The deconvolution was performed using CIBERSORT with a custom gene expression generated from 
the data set in [47]. 
 
 
(B) Gating strategy and  






increases with age. This result also correlates with our previous findings showing that the 
Lin28a tg causes more profound changes in TEC development and function as the mouse ages.  
 A Gene Set Enrichment (GSE) analysis of the differentially regulated genes in 2 week 
old Lin28a tg cTEClo showed a down-regulation of pathways related to the immune system, 
while there were no pathways that trended to be over-expressed in the mutant cells when 
compared to control (Figure 23B). In 2 week old Lin28a tg cTEChi, I found that immune system 
and cell cycle pathways were down-regulated while collagen biosynthesis and extracellular 
matrix organization pathways trended to be over-expressed compared to control (Figure 23B). 
7 week old cTEClo of Lin28aTEC mice did not display any significant changes in reactome 
pathway enrichment compared to control (Figure 23B). cTEChi of 7 week old Lin28aTEC 
showed reduced immune and GPCR signaling whereas MAP kinase activation and IL-17 





Figure 23: The impact of Lin28a tg on the transcriptome of cTEC increases with age 
(A) MA-plot displaying the average expression (x-axis) versus the fold-change (log2) 







4.7.3 Epithelial to mesenchymal transition is increased in cTEC that express Lin28a tg at 7 
weeks of age 
I next mapped the differentially expressed genes in 2 and 7 week old Lin28a mutant 
cTEC to Reactome pathways. 2 week old Lin28a tg cTEClo showed a significant increase in 
pathways dealing with the tricarboxylic acid cycle (TCA), respiratory electron transport chain 
and complex I biogenesis while cTEChi of 2 week old Lin28aTEC displayed enhanced 
extracellular matrix organization, cell cycle and epithelial to mesenchymal transition (Figure 
24A). In 7 week old Lin28aTEC mice, I found that both cTEClo and cTEChi displayed an up-
regulation in pathways related to extracellular matrix organization, kras signaling up and 
epithelial to mesenchymal transition (EMT) (Figure 24B). The latter pathway was previously 
described to contribute to thymic involution by reducing absolute TEC numbers, in line with 
our observations that adult Lin28aTEC mice show reduced thymic size and absolute TEC 
numbers (Figure 12A, 12I) [129, 130, 131]. Hence, this result suggests that the up-regulation 
of EMT in cTEC by Lin28a tg contributes to the loss of TEC and subsequent thymic shrinkage 
in these mice.   
 
 
of genes in 2 and 7 week old Lin28a tg cTEClo and cTEChi versus control. Differentially expressed 
(DE) genes are shown in green. The number of DE genes (up/down) are shown along the left-side of 
the axis in green. (B) Gene set enrichment analysis for 2 and 7 week old Lin28a tg cTEClo and cTEChi. 
The differentially regulated genes in each pathway are represented by bars in rank order from 0 (most 
upregulated) to 300, 2000 or 3000 (most downregulated). The height of the bar signifies the amount of 
the gene that is up or down regulated. The normalized enrichment score (NES) visualizes if there are 
more up or downregulated genes in the pathway. A positive NES value indicates that the pathway is 
more enriched in the up regulated genes while a negative NES value shows that the pathway is more 






Figure 24: Epithelial to mesenchymal transition is increased in cTEC that express Lin28a tg at 7 
weeks of age 
(A) Dot plots displaying Molecular Signatures Database (Hallmark) enriched pathways in 2 week old 
Lin28a tg cTEClo and cTEChi. (B) Dot plots displaying Molecular Signatures Database (Hallmark) 
enriched pathways in 7 week old Lin28a tg cTEClo and cTEChi. The x-axis shows the gene ratio 
(differentially expressed genes in a certain pathway over total differentially expressed genes). The size 
of the dot corresponds to the number of differentially expressed genes in that pathway. The color of 





4.7.4 WNT signaling is down-regulated in Lin28a tg cTEC from 2 to 7 weeks of age  
Considering that juvenile Lin28aTEC mice showed normal cTEC subset composition 
while young adult Lin28a mutant mice displayed an increased cTEChi/cTEClo ratio, I next 
analyzed which transcriptomic changes occur in cTEClo and cTEChi from 2 weeks to 7 weeks 
of age. With age, control cTEClo increased genes related to extracellular matrix organization, 
metabolism of lipids and proteins, post-translational protein modification and WNT signaling. 
In contrast, Lin28a tg cTEClo increased the expression of transcripts associated with 
intracellular and G alpha signaling, immune system and hemostasis with age (Figure 25A). In 
control cTEChi, the expression of genes involved in GPCR ligand binding, ion channel 
transport and signaling by WNT were enhanced while transcripts related to RNA metabolism, 
cellular stress and antigen processing were increased in Lin28a tg cTEChi from 2 to 7 weeks of 
age (Figure 25B). As both cTEC subsets from control animals showed an increase in WNT 
signaling with age, this result suggests that this signaling pathway is important for the 
maintenance and maturation of cTEC. This hypothesis is also in line with earlier reports 
showing that inhibition of WNT signaling in post-natal mice leads to the loss of TEC 
progenitors and thymic atrophy [132]. Also, decreased WNT signaling in TEC has been 
described to drive EMT in these cells [133, 134]. Hence the reduced signaling by WNT in 
Lin28a tg cTEC correlated with the up-regulation of EMT associated genes in these cells. 
Together, this result implies that Lin28a tg reduces WNT signaling in TEC from juvenile to 
adult age which induces the up-regulation of EMT and subsequent depletion of TEC 















































Figure 25: WNT signaling is down-regulated in Lin28a tg cTEC from 2 to 7 weeks of age 
(A) Pathway enrichment comparison between Lin28aCtrl and Lin28aTEC cTEClo from 2 to 7 week old 
mice. Pathways increased in control cTEClo are shown in the lower right box while pathways enriched 
in Lin28a tg cTEClo are displayed in the upper left box. (B) Pathway enrichment comparison between 


























shown in the lower right box while pathways enriched in Lin28a tg cTEChi are displayed in the upper 
left box. NES = Normalized estimation score; a positive value visualizes that the DE genes are skewed 







4.8 Molecular consequences of Lin28a ectopic expression in TEC 
4.8.1 Lin28a tg re-programs metabolism of cTEChi from oxidative phosphorylation to 
glycolysis  
I next explored metabolic pathways allowing Lin28a tg cTEChi to maintain high 
proliferative rates [135, 136, 137, 138]. Cell division is an energetically challenging process 
that requires the synthesis of proteins, lipids and nucleic acids. Highly proliferating cells such 
as cancer, cells often reprogram their metabolism from oxidative phosphorylation (OxPhos) to 
increased glycolysis to produce metabolites for the synthesis of macromolecules in the pentose 
phosphate and L-serine biosynthesis pathway [137, 138]. In order to investigate whether 
Lin28a tg cTEChi also rewire their metabolism to support their high proliferative rates I 
employed the technique single-cell energetic metabolism by profiling translation inhibition 
(SCENITH), a method that is designed to reveal metabolic profiles of single cells by measuring 
protein translation rates using flow cytometry [139].  
I quantified protein synthesis with puromycin which, as a mimic of tyrosyl-tRNA, is 
incorporated into the growing polypeptide chain and detected with a puromycin specific 
antibody [140]. To reveal the dependency on different metabolic pathways, the cells are treated 
with various metabolic inhibitors. The more a cell depends on a particular pathway, the more 
it will down-regulate its protein synthesis activity upon blockade of that metabolic pathway. 
Glycolysis is hereby inhibited using the non-metabolizable glucose analog 2-Deoxyglucose (2-
DG). Oligomycin, a complex V inhibitor of the mitochondrial electron transport chain, is added 
to block ATP production via OxPhos and fatty acid and amino acid metabolism. To inhibit 
glycolysis, OxPhos as well as fatty acid and amino acid metabolism, 2-DG, oligomycin and 
Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP), an ionophore that disrupts the 




In the absence of inhibitors, puromycin incorporation is similar between control and 
Lin28a tg cTEChi, suggesting a comparable metabolic activity of mutant and control cells in 
the steady-state case (Figure 26B). Blocking glycolysis by adding 2-DG enhanced protein 
translation cTEChi from control animals, hence implying increased energy metabolism. In 
contrast, cTEChi of Lin28a mutant mice significantly reduced their puromycin incorporation in 
response to 2-DG treatment, suggestive of reduced metabolism (Figure 26B). This result 
implies that cTEChi of control mice are able to rewire their metabolic prolife from glycolysis 
to OxPhos via fatty acid and/or amino acid metabolism upon 2-DG treatment while Lin28a tg 
cTEChi are unable to switch their metabolism and hence depend on glycolysis. Treating the 
cells with oligomycin and all inhibitors (2-DG, oligomycin and FCCP) had a similar effect in 
control and mutant cTEChi, suggesting a comparable OxPhos and fatty acid or amino acid 
activity (Figure 26B). 
To understand why Lin28a tg cTEChi are unable to switch to OxPhos upon 2-DG 
treatment, I next analysed the number of mitochondria in these cells using MitoTracker dye, a 
probe that contains a reactive chloromethyl moiety which forms covalent bonds with thiol 
groups in the mitochondria and thus permanently labels mitochondria. I found that the number 
of mitochondria was significantly reduced upon Lin28a over-expression in cTEChi (Figure 
26C). Hence, the reduced number of mitochondria in Lin28a tg cTEChi correlated with the 
inability of these cells to rewire from glucose metabolism to OxPhos. 
To further dissect the molecular mechanisms of the observed changes in energy 
metabolism, I then performed proteomic analyses. Two of the key enzymes that are involved 
in fatty acid metabolism, namely Acyl-CoA dehydrogenase (Acadm) and 3-Ketoacyl CoA 
thiolase (Acaa2), were significantly reduced by Lin28a in cTEC (Figure 26D). In addition, 
Aldolase B (Aldob) and Aldolase C (Aldoc), enzymes that are involved in glucose metabolism, 




protein expression of metabolic enzymes were not observed in Lin28b mutant cTEC, 
suggesting a Let-7 independent effect of Lin28a on energy metabolism of TEC.  
As enhanced glucose dependency requires increased glucose uptake, I measured the 
expression of glucose transporter 4 (Glut4), a protein that is known to be positively regulated 
by Lin28a [98]. Lin28a was shown to enhance Glut4 translation in muscle cells via increasing 
the expression of genes in the Insulin-PI3K-mTOR pathway namely Insulin-like growth factor 
1 (Igf1r), Insulin receptor (Insr) and Insulin receptor substrate 2 (Irs2). Indeed, protein 
expression of Glut4 was significantly higher in mutant cTEChi when compared to control 
(Figure 26E). I then tested the expression of Igf1r, Insr and Irs2 via qPCR in Lin28a tg cTEChi 
and found that all three genes were significantly up-regulated in the mutant cells when 
compared to control (Figure 26F). 
Together, our results suggest that Lin28a tg cTEChi depend more on glycolysis due to 
reduced fatty acid oxidation and decreased mitochondrial number and meet this dependency 






































Figure 26: Lin28a tg re-programs metabolism of cTEChi from oxidative phosphorylation to 
glycolysis 
(A) Overview of the different metabolic pathways that can be measured via SCENITH and their 
metabolic inhibition. (B) Representative histograms and metabolic profile of cTEChi after SCENITH 
analysis. Data representative of one experiment analyzing new-born Lin28aTEC and control mice. (B) 
Quantitative analysis of MitoTracker in cTEChi using median fluorescence intensity of Mitotracker 
divided by FSC-W3. Data is representative of three independent experiments analyzing mutant and 
control female animals at 4-5 weeks of age. (C) Volcano plot displaying fold change and statistical 






4.8.2 Ectopic Lin28a increases the activation of MAPK in cTEClo and mTEC 
Lin28a over-expression increased TEC apoptosis, as indicated by increased cleaved 
Caspase-3 detection (see Figure 13D). To identify mechanisms and pathways that account for 
the observed change in TEC survival by Lin28a tg, I compared the gene expression profile of 
total cTEC from young adult mutant mice to cells from Lin28aCtrl animals. The reason for 
combining cTEChi and cTEClo for this study was that I aimed for a more in-depth analysis of 
the transcriptomic changes imposed by Lin28a tg. 
This analysis revealed an up-regulation of transcripts involved in mitogen activated 
kinases (MAPK) signaling in Lin28a tg cTEC (Figure 27A). MAPK are Ser/Thr kinases that 
convert a variety of extracellular stimuli, such as radiation, cellular stress, growth factors, into 
a wide range of cellular responses [141]. In mammals, there are more than a dozen MAPK 
enzymes that coordinately regulate cell proliferation, differentiation, motility, and survival 
[142, 143, 144]. The best known are the conventional MAPK, which include the extracellular 
signal-regulated kinases 1 and 2 (ERK1/2), c-Jun amino-terminal kinases (JNK) 1 to 3, p38 (α, 
β, γ, and δ), and ERK5 families. A more refined analysis revealed that increased MAPK activity 
mapped to JNK signaling (Figure 27B). As JNK signaling is involved in apoptosis, its up-
regulation in Lin28a tg TEC correlated with the observed increase of cell death (Figure 13D). 
analysis. Data representative of one experiment analyzing new-born Lin28aTEC and control mice. (C) 
Quantitative analysis of MitoTracker in cTEChi using median fluorescence intensity of Mitotracker 
divided by FSC-W3. Data is representative of three independent experiments analyzing mutant and 
control female animals at 4-5 weeks of age. (D) Volcano plot displaying fold change and statistical 
significance of all detected proteins between control and mutant cTEC from 4-5 week old female mice. 
Enzymes of glycolysis and fatty acid metabolism that are significantly enriched or depleted by Lin28a 
tg are annotated. (E) Quantification of Glut4 expression in transgenic and control cTEChi using Glut4 
geometric median fluorescence intensity (gMFI). Data representative of two independent experiment 
analyzing Lin28aTEC and control female mice at 4-5 weeks of age. (F) Expression of Igf1r, Insr and 
Irs2 in cTEChi. Data is representative of two independent experiments analyzing Lin28aTEC and 
Lin28aCtrl female mice at 2 weeks of age. qPCR normalized to Gapdh expression. * p < .05, ** p < .01, 






Hence, I probed the activation of MAPK signaling in TEC of Lin28aTEC animals by measuring 
the phosphorylation state of TAK1 which is the central hub of the MAPK pathway [145].   
 The percentage of phosphor-TAK1 positive cTEClo and mTEC was increased in 
Lin28aTEC mice while the frequency of activated TAK1 positive cTEChi was similar between 
mutant and control animals (Figure 27C, 27D). Furthermore, cTEClo and mTEC expressing 
Lin28a transgene showed increased phosphorylation of TAK1 when compared to control TEC 
(Figure 27E). In contrast, TAK1 phosphorylation was comparable between experimental and 
control mice when analysed for cTEChi (Figure 27D, 27E). Hence, this result shows that Lin28a 
tg increases the activation of MAPK in cTEClo and mTEC as measured by TAK1 activation. 
Furthermore, this data corroborates the increased apoptosis observed in these cells in Lin28aTEC 
animals (see Figure 13D). Taken together, this data implies that Lin28a mediates activation of 














Figure 27: Ectopic Lin28a increases the activation of MAPK in cTEClo and mTEC  
(A) Reactome pathways enriched in Lin28a tg cTEC. The differentially regulated genes in each 
pathway are represented by bars in rank order from 0 (most up-regulated) to 3000 (most down-
regulated). The height of the bar signifies the amount of the gene that is up- or down-regulated. The 
normalized estimation score (NES) visualizes if there are more up- (i.e. positive NES value) or down-
regulated (i.e. negative NES value) genes in the pathway. (B) List of the MAPK cascade genes that are 
up-regulated by Lin28a in cTEC and their respective log2fold change compared to control cTEC. (C) 
Representative plots of phosphorylated TAK1 (Thr184/187) (p-TAK1) positive cTEClo, cTEChi and 
mTEClo, mTEChi, tm mTEC. (D) Frequency of p-TAK1 positive TEC subset. (E) Quantification of 
TAK1 activation in p-TAK1pos TEC subsets using p-TAK1 gMFI. Data representative of two 
independent experiment analyzing Lin28aTEC and Lin28aCtrl female mice at 4 weeks of age. * p < .05, 




4.8.3  Lin28a tg TEC show higher Foxo3a expression and increased activation of JNK 
Interleukin-1 receptor type 1 (IL-1R1), Toll-like receptor (TLR) 2 and 4 as well as 
tumor necrosis factor-receptor 1 (TNF-R1) are placed upstream of TAK1 and hence might 
induce the signaling cascade [146]. I analyzed the expression levels of these receptors in 
Lin28a mutant cTEC using our bulk transcriptomic data. While Tlr2, Tlr4 and Il-1r1 were 
expressed at very low copy numbers, Tnfrsf1a, the gene encoding TNF-R1, was highly 
expressed in cTEC of Lin28aTEC mice (Figure 28A). Moreover, TNF-α is known to induce 
apoptosis through TNF-R1, suggesting that Lin28a tg TEC are experiencing TNF-R1 signaling 
and subsequent MAPK activation, leading to increased cell death [147]. Supporting this 
assumption, I found a strong increase of a TNF-α inducible gene, namely Tnfsf15 (encoding 
vascular endothelial growth inhibitor; VEGI) in Lin28a tg cTEC (Figure 28B) [148].  
TNF-R1 induces cell death via its cytoplasmic death domain in a variety of cells [149]. 
Although it was demonstrated that the death-inducing capability of TNF is masked by 
concomitant activation of NF-kB and its pro-survival effect, our data implies that in Lin28a tg 
TEC the pro-apoptotic effect of TNF-alpha dominates over NF-kB activation. Significant up-
regulation of Foxo3a transcription, a molecule that is known to direct TNF-receptor signaling 
towards apoptosis through suppressing NF-kB activity, supports this assumption (Figure 
28C) [150, 151]. As it was shown that FOXO3A promotes apoptosis through activation of JNK 
and suppression of NF-kB, I next tested whether JNK is activated in Lin28a mutant TEC. The 
percentage of phosphor-c-Jun positive TEC was increased in TEC of Lin28aTEC mice (Figure 




Jun when compared to control TEC (Figure 28F). Hence, our results imply that Lin28a tg 
mediates higher activation of MAPK and c-Jun signaling and thus increased cell death in TEC. 
Figure 28: Lin28a tg TEC show higher Foxo3a expression and increased activation of JNK 
(A) Expression levels of Epcam, Enpep (gene encoding Ly51), Tlr2, Tlr4, Il-1r1 and Tnfrsf1a 
(encoding TNF-R1) in Lin28a tg cTEC using baseMean. The baseMean is the average of the 
normalized counts taken over all samples.  (B)  Log2FoldChange of Tnfsf15 in Lin28a tg cTEC 
compared to control. (C) Expression of Foxo3a in cTEClo, cTEChi, mTEClo and mTEChi. Data is 
representative of two independent experiments analyzing Lin28aTEC and Lin28aCtrl female mice at 4-7 
weeks of age. qPCR normalized to bACT expression. (D) Representative plots of phosphorylated c-Jun 
(Ser63) (p-c-Jun) positive cTEClo, cTEChi and mTEClo, mTEChi, tm mTEC. (E) Frequency of p-c-Jun 
positive TEC subset. (F) Quantification of c-Jun activation in TEC subsets using p-c-Jun gMFI. Data 
representative of two independent experiment analyzing Lin28aTEC and Lin28aCtrl female mice at 4-5 







4.8.4 TNF-R1 expression is higher in Lin28a tg TEC and TNF-α increases TEC apoptosis 
upon NF-kB inhibition  
To find out whether the heightened susceptibility of Lin28a tg TEC to cell death is 
driven by higher TNF-R1 expression, I next tested its surface expression in Lin28a mutant and 
control TEC. Indeed, TNF-R1 surface expression was significantly higher in Lin28a tg cTEClo 
and mTEC when compared to control cells of the same phenotype (Figure 29A). This data 
correlates with the increased apoptosis rates of these cells in Lin28aTEC animals and indicates 
that cTEClo and mTEC expressing Lin28a tg experience higher TNF-alpha stimulation through 
increased TNF-R1 expression and that FOXO3A directs this signal in these cells towards 
apoptosis by inhibiting NF-kB activation. 
To mechanistically prove this hypothesis, I incubated thymic lobes of new-born 
animals, in medium only, in the presence of TNF-α only or TNF-α and the NF-kB inhibitor, 
Ammonium pyrrolidineedithiocarbamate (APDC) and analyzed the percentage of activated 
Caspase-3 positive TEC. Indeed, the frequency of apoptotic TEC was significantly higher in 
the lobes treated with TNF-α plus APDC compared to non-treated or TNF-α only treated lobes 
(Figure 29B, 29C). This result supports our hypothesis and indicates that the enhanced 
susceptibility of Lin28a tg cTEClo and mTEC to apoptosis is driven by increased TNF-R1 
signaling and that FOXO3A drives this signal towards apoptosis by inhibiting the activation of 


















Figure 29: TNF-R1 expression is higher in Lin28a tg TEC and TNF-α increases TEC apoptosis 
upon NF-kB inhibition 
(A) Quantification of TNF-R1 surface expression in TEC subsets using TNF-R1 gMFI. Data is 
representative of two independent experiment analyzing Lin28aTEC and Lin28aCtrl female mice at 5 
weeks of age. (B)  Representative gating strategy and (C) quantitative analysis of cleaved Caspase-3 
positive TEC in new-born thymic organ cultures (NTOC). Thymic lobes for NTOC were isolated from 
wild-type animals at 1 day of age, cut into half and cultured in medium only, in the presence of          
TNF-α or TNF-α plus Ammonium pyrrolidinedithiocarbamate (APDC) at 37° overnight. Data is 







5. Summary of findings 
Whereas Lin28aTEC mice display an hypocellular thymus, Lin28b transgenic expression 
causes hyperplasia of the thymus. In both mutant mouse models, the absolute number of ETP 
correlates with thymocyte numbers and thymic size. Size and composition of the TEC 
compartment is differentially affected as well, Lin28a tg mice displaying normal cTEC 
cellularity but 3-4 fold reduced mTEC numbers whereas Lin28b transgenesis causes a 
prominent increase in cTEC and a slight rise in mTEC cellularity. The transgenic expression 
of Lin28 also impairs cTEC and mTEC subset compositions. The frequency and number of 
cTEClo is reduced by 4-5 fold in Lin28aTEC mice while the cTEChi:cTEClo ratio is unchanged 
in Lin28bTEC mice. The relative numbers of mTEClo and tm mTEC is reduced in both Lin28a 
and Lin28b mutant mice while the frequency of mTEChi is only increased in Lin28aTEC animals. 
The underlying mechanisms that lead to these changes following a TEC-targeted transgenic 
expression of Lin28a are epistatic, as the phenotype of animals expressing concurrently Lin28a 
and Lin28b is comparable to that of Lin28aTEC mice.  
 
The reduced cellularity of cTEClo and mTEC in Lin28aTEC mice correlates with an 
increased signal of activated Caspase-3, indicating decreased cell survival. The heightened 
susceptibility of cTEClo and mTEC to cell death is explained by increased MAPK signaling in 
these cells which is driven by TNF-R1 mediated signals. Under wild-type conditions, TNF-R1 
activation leads to cell survival through suppression of JNK and caspase-3 activation by NF-
κB. cTEClo and mTEC expressing Lin28a transgenically, however, demonstrate higher TNF-α 
stimulation secondary to increased TNF-R1 expression and Foxo3a, a transcription factor 







The increased number of cTEChi in Lin28aTEC mice is likely explained by the cells’ 
higher proliferation. The ability of Lin28a tg cTEChi to proliferate more than control cells is 
metabolically supported by their higher glucose usage. Enhanced glycolysis in Lin28a tg 
cTEChi is hereby mediated through higher expression of glycolysis enzymes, namely Aldolase 
B and Aldolase C as well as increased insulin signaling, leading to more Glut4 surface 
Figure 30: Lin28a tg TEC undergo TNF-R1 induced cell death 
Upon TNF-α stimulation, TNF-R1 forms complex I, in which RIPK1 acquires a polyubiquitin chain. 
The formation of the TNF-R1 complex I leads to the phosphorylation of TAK1 which in turn activates 
JNK as well as NF-κB. In addition, complex I can also dissociate from TNF-R1, leading to the 
formation of complex II, which is composed of Caspase-8/10, TRADD, FADD, TRAF2 and RIPK1. 
The formation of complex II initiates the caspase cascade, which leads to apoptosis. In wild-type TEC, 
NF-κB signaling through TNF-R1 activation leads to cell survival through suppression of JNK and 
caspase activation by NF-κB. Lin28a tg TEC, however, experience higher TNF-α stimulation by 
increased TNF-R1 expression and Foxo3a, which directs this signal in these cells towards apoptosis by 
inhibiting NF-κB activation. Abbreviations: TNF: Tumor necrosis factor; TNF-R1: TNF-receptor type 
1; TRADD: TNF-R1-associated death domain protein; FADD: Fas-associated protein with death 
domain; TRAF2: TNF-R-associated factor 2; RIPK1: Receptor-interacting serine/threonine-protein 
kinase 1; cIAP: Cellular inhibitor of apoptosis; TRAF6: TNF-R-associated factor 6; TAK1: 
Transforming growth factor-β-activated kinase 1; TAB2: TAK1-binding protein 2; MKK: Mitogen-
activated protein kinase; NF-κB: Nuclear Factor-κB;  JNK: c-Jun N-terminal kinases; NEMO: Nuclear 





expression. However, the increased glucose usage of Lin28a tg cTEChi is most likely also a 
result of reduced mitochondrial numbers and decreased fatty acid oxidation in these cells 
(Figure 31).  
 
Figure 31: Lin28a over-expression in TEC leads to higher glucose usage through positive 
regulation of the Insulin-PI3K-mTOR pathway 
Cells can generate adenosine triphosphate (ATP) through different metabolic pathways. One of the 
major energy metabolism pathways is glycolysis, which starts with the uptake of glucose through 
glucose transporters. Glucose uptake can be stimulated by insulin and IGF1/2 which activate the INSR 
and IGF1R, respectively. This then leads to the phosphorylation IRS2 which activates AKT through 
PI3K. Activated AKT induces the translocation of GLUT4 from vesicular compartments onto the 
plasma membrane of the cell, leading to increased glucose uptake. Once glucose is taken up, it is 
processed to pyruvate through a number of enzymes. In the presence of oxygen, pyruvate is being 
converted into Acetyl-coenzyme A (Acetyl-CoA) that enters the tricarboxylic acid (TCA) cycle and 
provides reducing intermediates NADH and FADH2 for the electron transport chain in the 
mitochondria. However, fatty acid ß-oxidation also generates Acetyl-CoA which fuels the TCA cycle 
and produces intermediates for the mitochondrial electron transport chain. Glucose usage is higher in 
TEC that express Lin28a tg due to their enhanced expression of glycolytic enzymes as well as increased 
GLUT4 surface density which is mediated by INSR/IGF1R signaling.  Moreover, Lin28a tg TEC have 
decreased expression of enzymes involved in fatty acid ß-oxidation and reduced number of active 
mitochondria. Abbreviations: IGF: Insulin-like growth factor; IGF1R: Insulin-like growth factor 1 
receptor; INSR: Insulin receptor; IRS2: Insulin receptor substrate 2; PI3K: Phosphoinositide 3-kinase; 





The TEC subset changes identified in Lin28a tg animals correlate with alterations in 
thymocyte maturation, as these mice display reduced numbers of (i) positively selected 
thymocytes, (ii) negatively selected wave 1 cells, (ii) Foxp3 positive regulatory thymocytes 
and (iv) cytokine licensed CD69neg, CD24lo mature SP cells. Further detailed analyses provided 
convincing molecular mechanisms that account for these findings, for example the decrease in 
positive selection paralleled an increased frequency of PD-L1pos cTEChi. This subpopulation 
of TEC is less effective in thymocyte positive selection due to their high PD-L1 cell surface 
expression and is found at a higher abundance in Lin28aTEC animals (Figure 32). 
 
 
Figure 32: Adult Lin28aTEC mice have increased frequency of cTEChi which are less effective in 
thymocyte positive selection 
Thymocytes are tested for their TCR avidity to self-peptide/MHC-complexes expressed on cTEC. Most 
thymocytes die by neglect as they do not recognize self-peptide/MHC-complexes. Cells that have a 
TCR with medium avidity are positively selected and continue their development while thymocytes 
with high binding strengths are negatively selected and removed from the repertoire. In adult Lin28aTEC 
mice, however, the existing cTEC are mainly of the cTEChi phenotype, i.e. cells that highly express 
MHCII on their surface. It is therefore probable that cTEChi, which have large amounts of the ligand 
for TCR plus PD-L1, set a signal threshold window where thymocytes with high TCR avidities are 






Short, non-coding RNAs belonging to the miRNA family regulate organ development 
and function by targeting multiple components of regulatory networks controlling self-renewal 
and lineage determination [152]. The general importance of miRNAs for the maintenance of a 
regular composition and function of the thymic microenvironment has been unequivocally 
demonstrated using experimental conditions that ablated their Dicer-dependent progeny in 
TECs [83]. Furthermore, a number of individual miRNA, namely miR-181a, miR-449a and 
miR-155 have been shown to play an essential role in TEC biology [84, 85, 86].  Although 
these studies provided evidence for the importance of miRNAs for the development and 
function of thymic epithelia, the precise role of the majority of the up to 2000 individual mouse 
miRNAs in TEC biology remains largely unknown.  
 
The dependence of TEC differentiation and function on the miRNA family Let-7 and 
on the epigenetic regulation by the RNA binding proteins Lin28A and Lin28B has been 
investigated in the presented experimental work. In general, overlapping biological effects 
have been attributed to Lin28a and Lin28b with both controlling the switch between 
pluripotency and cell differentiation. Lin28a over-expression leads to increased total body and 
organ sizes maintaining normal proportions [153]. Hence, the biological activity of sustained 
suppression of Lin28a controlled mRNA correlates with increased proliferation and 
consequently cell numbers [153]. When studying thymic organ size in the Lin28 mutant mice, 
a hypocellular thymus is observed in Lin28a transgenic animals whereas Lin28b over-
expression causes thymic hyperplasia. The thymic epithelial compartment is therefore to our 
knowledge the first example where Lin28a and Lin28b exert distinct roles in regulating organ 
size. Moreover, the underlying mechanisms that lead to these effects by Lin28a transgenesis 




animals. Thus, our study reveals a previously unrecognized epistatic relationship between these 
RBPs in controlling thymus organ size. In addition, the different expression levels of Lin28a 
tg and Lin28b tg in TEC may also have an influence on thymic size regulation.    
 
Studying the TEC compartment in Lin28 mutant young adult mice, a decrease in overall 
TEC cellularity is observed in Lin28aTEC animals while Lin28bTEC mice show a significant 
increase in total TEC numbers, correlating with the changes in absolute thymus cellularity 
found in these mice and highlighting further the opposing effects of both RBPs. cTEClo and 
mTEC of Lin28aTEC mice are more prone to apoptosis and have unchanged proliferative 
capacity, correlating with their reduced absolute numbers. This suggests that extensive TEC 
apoptosis in Lin28aTEC mice contributes to the reduction in absolute TEC numbers in these 
mice. In addition to cell death, the decrease in overall TEC cellularity in Lin28a mutant mice 
could also be due to: (i) reduced numbers of TEC progenitors or (ii) increased EMT process. 
The first possibility is supported by our data showing that Lin28a tg expression reduces WNT 
signaling in TEC, a pathway shown to be involved in the maintenance of CK5+CK8+ TEC 
progenitors in the post-natal mouse [132]. Others have reported that the WNT signaling 
pathway directly induces Lin28a up-regulation and subsequent Let-7 down-regulation [154]. 
Therefore, it is possible that there is a WNT/Lin28A negative feedback loop in which ectopic 
Lin28A inhibits WNT activity. Furthermore, decreased WNT signaling in TEC has been 
described to foster EMT, resulting in a reduction of total TEC numbers [133, 134]. Our data 
shows that Lin28a expression in cTEC correlates increased expression of genes related to EMT. 
The observed reduction of TEC cellularity consequent to targeted Lin28a expression may 





Over-expression of Lin28b, however, has no significant effect on TEC proliferation. 
This suggests that the increased number of TECs in Lin28bTEC animals might be due to 
metabolic fitness achieved by enhanced mitochondrial function and glucose usage. In addition, 
increased TEC cellularity by Lin28b tg may also be mediated by a prolonged lifespan, a 
possibility that is in line with a recent finding showing that Lin28b promotes colon cancer 
development by increasing the expression of the pro-survival protein B-cell lymphoma 2 
(BCL-2) and improving its protein stability [155].  
 As the TEC subset composition of Lin28bTEC mice displays only minor differences 
compared to that of wild-type mice, I conclude that Lin28b tg has rather an effect on TEC 
metabolism and survival which contributes to the enlargement of the thymus and focused on 
the biological changes mediated by Lin28a tg. 
 
Young adult Lin28a mutant mice display a regular segregation of the thymus into 
individual cortical and medullary compartments, parallel to a relative increased number of 
cTEC. The frequency of apoptotic TECs in Lin28aTEC is increased among mTEC, indicating 
that the displayed change in the ratio of cortical to medullary TEC in favor of the cTEC is a 
combination of higher proliferation (cTEC) and cell death (mTEC). There are, however, also 
other possible explanations for this finding. cTEC and mTEC derive from a common bipotent 
progenitor present at high frequency in the embryonic and neonatal thymus [36, 37, 38]. The 
immediate progeny of these cells first attain a cTEC-like phenotype and subsequently diverge 
to the mTEC lineage [40, 41]. My results are therefore also comparable with a model where 
Lin28a over-expression mediates a maturational block of precursors adapting on a mTEC 
lineage tale, thus contributing to an overall decrease of mTECs. This explanation is also in line 
with the reduced signal of intertypical TEC in 7 week old Lin28a tg cTEChi, which are the 




abundant in the post-natal mouse, which derive from a β5t+ precursor cell and that are able to 
differentiate into mTEC [47]. Further detailed investigations will, however, be necessary to 
phenotypic characterize intertypical TEC in order to quantify their numbers in Lin28aTEC 
animals.  
 
Young adult Lin28aTEC animals show an increase in the frequency of cTEChi. 
According to transcriptomic analyses and in vivo transplantation assays cTEClo can 
differentiate into cTEChi in post-natal tissues [49, 127]. However, cTEChi are the first cTEC 
subset that arises during fetal development, while cTEClo only emerge one week after birth and 
steadily increase as the animal ages, suggesting that cTEClo differentiate from cTEChi in 
juvenile mice. Hence, the phenotypic transition between cTEChi and cTEClo is an age-
dependent process. My results, however, imply that ectopic Lin28a expression locks cTEC in 
a cTEChi stage and blocks their transition into a cTEClo phenotype. This hypothesis is in line 
with our results from juvenile mice showing that the cTEChi:cTEClo ratio is unchanged in 
Lin28a mutant mice at this age. As it currently debated whether cTEClo also arise 
independently of cTEChi from a separate progenitor that is only present in the post-natal animal, 
it could also be that Lin28a tg (i) reduces the pool of these post-natal cTEC progenitors and/or 
(ii) impairs the maturation of cTEClo from post-natal progenitor cells. Future work will need 
to identify the exact progenitor:progeny relationships between the different TEC subsets during 
pre-natal and post-natal life. Moreover, Lin28a tg cTEC fail to up-regulate WNT signaling at 
7 weeks of age, implying that this pathway, besides being involved in the maintenance of post-
natal TEC progenitors, is also important for further cTEC differentiation. This is not surprising, 
as signaling through WNT was shown to promote cell differentiation in various tissues [160, 
161, 162, 163]. In addition, WNT signaling needs to be precisely regulated to control normal 




tg cTEClo have increased cell death rates, suggesting that the increased rate of apoptosis in 
cTEClo might also be responsible for the reduction in the population size of cTEClo. 
Within the mTEC compartment of young adult Lin28a mutant mice the frequency of 
mTEClo is reduced while that of terminally mature mTEC and mTEChi increased, implying that 
Lin28a tg also regulates mTEC maturation, specifically at the transition of mTEChi to 
terminally mature mTEC. Foxo3a, a molecule which is known to block signaling trough the 
NF-kB pathway is over-expressed in mTEC of Lin28aTEC animals [150, 151]. As signaling via 
NF-kB regulates the maturation of mTEC this implies that the alterations in the mTEC subset 
composition of Lin28aTEC animals may be caused by increased Foxo3a expression [162,  163]. 
Because NF-kB signaling also controls the size of the mTEC compartment [162, 163], this data 
implies that increased Foxo3a expression could also be responsible for the reduction in 
absolute mTEC numbers in Lin28a tg animals.  
 
The main thymus size determining factor is the absolute number of DP thymocytes that 
derive from ETP. Hence, the attraction and/or survival of ETP play a crucial role in regulating 
thymic size. Whereas thymus cellularity is clearly distinct in Lin28aTEC and Lin28bTEC mice, 
the expression of chemokines important for ETP homing is similarly affected by both 
transgenes, implying Let-7 dependent mechanisms regulating chemokine expression. Hence, 
this data implies that the differences in thymic organ size are mainly driven by changes in the 
absolute number of TEC in Lin28aTEC and Lin28bTEC mice. Reduced thymic cellularity in 
Lin28a tg mice can be explained by a decrease in TEC numbers that express reduced amounts 
of the ETP attractant Ccl21 and Ccl19. Lin28b tg animals show an increase in ETP and thymic 
cellularity despite Ccl21 reduction in mTEC. My studies revealed that in Lin28b tg TEC the 
expression of ETP attractant Cxcl12 is on a comparable level to that of control littermates and 




Cxcl12 and increased quantities of Ccl25 might compensate the reduced Cccl21 and Ccl19 
expression in TEC. These combined effects could lead to increased numbers of ETP correlating 
to the enlargement of the thymic organ in Lin28b tg mice. In addition, the contribution of other 
chemokines that are differentially regulated by Lin28a and Lin28b tg cannot be ruled out.  
 
 Transgenic expression of Lin28a compromises thymocyte positive selection as the 
frequency of CD4 and CD8SP thymocytes is reduced. The ability of the cTEC compartment to 
negatively select self-reactive thymocytes is also reduced by Lin28a. The defects in thymocyte 
positive selection correlate with an increased frequency of PD-L1 positive cTEC in young adult 
Lin28aTEC animals. PD-L1:PD-1 interaction had already been shown to negatively affect 
positive selection of CD4 SP thymocytes via inhibition of extracellular signal regulated kinase 
(ERK) activation and blocking BCL-2 up-regulation, two downstream events of TCR signaling 
that are crucial to thymocyte positive selection [128]. Indeed, blocking PD-L1 in wild-type 
FTOC increases the generation of CD4 SP thymocytes, as described [128], CD8 lineage 
selection is however not affected using this experimental approach.  
 
 PD-L1 is mainly expressed in cTEChi. Although it was shown that Let-7a and -7c 
directly bind to Pd-l1 mRNA and reduce its expression, I do not observe any change in the 
amounts of PD-L1 protein in Lin28aTEC mice when compared to control [112]. However, the 
low amounts of mature Let-7a and -7c in control TEC might not be sufficient to reduce PD-L1 
expression in TEC.   
 cTEC provide signals for early thymocyte development and restrict TCR specificities 
to self-MHC recognition. However, there have been so far no studies that investigated the 
function of different cTEC subsets which develop during thymus ontogeny. My studies have 




thymocytes when compared to cTEClo. Hence, the higher frequency of PD-L1hi cTEChi in 
Lin28aTEC mice explains, at least in part, the reduced capacity to positively select thymocytes. 
As positive selection is based on TCR avidity for self-MHC it is probable that cTEChi, which 
have large amounts of MHCII and PD-L1 on their surface, set a signal threshold window where 
thymocytes with higher TCR avidities are removed. As cTEChi are the predominant cTEC 
subset in juvenile animals, this implies that, early in life, thymic output contains fewer 
potentially auto-reactive T cell clones, a hypothesis that is also supported by Sharpe et al [128]. 
If not properly deleted, these cells have a competitive advantage against T cells with lower 
TCR avidity undergoing homeostatic expansion early in life [163] and lead to dysregulated 
immune responses such as autoimmunity and wasting disease [164]. Hence, my studies in a 
transgenic system provide novel insights into thymocyte maturation in wild-type animals. 
 
Lin28a tg cTEChi increase their glucose metabolism and this dependence is met by 
higher surface expression of the insulin sensitive Glut4, corroborating that insulin is involved 
in regulating glucose uptake in TEC [165]. In addition, TEC that express Lin28a tg show 
increased expression of Insr, Igf1r and Irs2 which are involved in the Insulin-PI3K-mTOR 
pathway and that are mechanistically linked to higher Glut4 expression [98, 166]. Hence, these 
studies provide novel insights into TEC energy metabolism on a single cell level.  
The increased usage of glucose in Lin28a over-expressing muscle cells was described 
by Zhu et al. [98] as being driven through Let-7-mediated repression of several components of 
the Insulin-PI3K-mTOR pathway. However, in addition to these Let-7 dependent results, I 
uncover some novel changes in metabolism, that are only observed in Lin28aTEC mice but not 
in Lin28bTEC animals, hence suggesting Let-7 independent mechanisms. Enzymes involved in 
the breakdown of glucose, namely Aldolase B and Aldolase C are increased on protein level in 




catalyze the reversible conversion of fructose-1,6-biphosphate to glyceraldehydes-3-phosphate 
(G3P) and dihydroxyacetone [166]. The increased expression of these enzymes correlates with 
our documented enhanced glucose dependency and Glut4 expression, thus further 
corroborating that Lin28a over-expression causes increased glucose usage.  
The number of mitochondria is reduced in Lin28a tg TEC, indicative of altered 
mitochondrial biogenesis in TEC. This is in contrast to a previous report showing that Lin28a 
over-expression increases the amount of mitochondria in cardiomyocytes [167]. However, 
different methodological approaches were taken to measure the number of mitochondria. While 
I used MitoTracker dye, a probe that chemically labels mitochondria, Wang et al. performed 
electron microscopy studies to determine the number of mitochondria. In addition, I worked 
with primary cells whereas Wang et al. studies were performed in cell lines.  
The reduced number of mitochondria correlates with a decrease in the expression of 
enzymes involved in fatty acid β-oxidation, a process that takes place in the mitochondrial 
matrix. Specifically, Acyl-CoA dehydrogenase and 3-Ketoacyl-CoA thiolase, are significantly 
depleted by Lin28a tg. Acyl-CoA dehydrogenase catalyzes the initial step of each cycle of fatty 
acid β-oxidation in the mitochondria of cells by oxidizing acyl-CoA thioesters, forming the 
corresponding enoyl-CoA. On the other hand, 3-Ketoacyl-CoA thiolase is involved in the last 
step of mitochondrial β-oxidation and catalyzes the thiolytic cleavage of 3-Ketoacyl-CoA into 
an Acetyl-CoA and a Fatty acyl-CoA shortened by two carbon atoms [168].  
Thus, our results indicate that Lin28a tg cTEChi depend more on glycolysis because of 
reduced fatty acid β-oxidation and impaired mitochondrial biogenesis and meet their 
dependency on glucose metabolism by increasing the expression of glycolytic enzymes. 
Furthermore, this data corroborates studies performed in cancer cells, which showed that these 
highly proliferating cells fuel their metabolic needs by increasing glycolysis and reducing 




even suggested that the Warburg effect is a common characteristic of cells with high 
proliferation rates.  Hence, our data implies that ectopic expression of Lin28a in TEC facilitates 
the Warburg effect to promote TEC proliferation, in line with a previous finding [170]. The 
authors of this study showed that this effect was mediated by increased expression of pyruvate 
dehydrogenase kinase 1 (PDK1) by Lin28a. PDK1 is a molecule that suppresses the activity of 
pyruvate dehydrogenase (PDH), an enzyme that catalyzes the conversion of pyruvate to acetyl-
CoA, thereby increases the influx of glycolysis derived acetyl-CoA into the TCA cycle.  
 
MAPK signaling defined by transcriptomics and TAK1 phosphorylation is significantly 
increased in TEC expressing Lin28a tg, a pathway known to trigger apoptosis in a variety of 
cells [142]. Furthermore, our transcriptomic data indicates that the activation of TAK1 has 
been mediated by TNF-alpha through TNF-R1. Indeed, I find increased expression of TNF-R1 
on cTEClo and mTEC of Lin28aTEC mice, correlating increased cell death with TNF-R1 induced 
MAPK signaling. However, I do not observe a significant difference in the expression of TNF-
R1 in Lin28a tg cTEChi. This subset could be less susceptible to changes mediated 
by ectopic Lin28a which eventually lead to differential TNF-R1 expression. This line of 
thought is supported by our bulk transcriptomics data showing a significant increase in estrogen 
signaling in 7 week old Lin28a tg cTEClo, but not in cTEChi. Estrogen is a sex hormone which 
is primarily responsible for the development of the reproductive system and physical 
characteristics of females and, of interest to this thesis, is known to increase TNF-R1 
expression [172, 173]. Hence, it may be that cTEClo and mTEC in Lin28aTEC mice are 






 The death inducing competence of TNF is normally balanced by simultaneous 
activation of NF-kB and its pro-survival effect [173]. However, our data suggests that 
in Lin28a tg TEC the pro-apoptotic effect of TNF-alpha overrules NF-kB activation. 
Supporting this hypothesis, Foxo3a, a transcription factor that is known to direct TNF-receptor 
signaling towards apoptosis through suppression of NF-kB activity and activation of c-Jun N-
terminal kinases activation (JNK) is significantly over-expressed in TEC that express Lin28a 
tg [150]. In line with this data, I find that the activation of JNK is increased in TEC of Lin28aTEC 
animals. Hence, our results imply that Lin28a tg cTEClo and mTEC experience higher TNF-
alpha stimulation through increased TNF-R1 expression and that Foxo3a diverts this signal in 
these cells towards apoptosis by inhibiting NF-kB activation and increasing JNK 
phosphorylation.  
Testing this hypothesis, I could confirm that TNF-alpha plus NF-kB inhibition 
significantly increased TEC apoptosis. Collectively, our data imply that the enhanced cell death 
rates of Lin28a tg cTEClo and mTEC is driven by increased TNF-R1 signaling and down-













This thesis reveals a previous unknown epistatic relationship between Lin28A and 
Lin28B in regulating thymus size and TEC function. Further experiments analyzing the direct 
targets of both RBPs will be required to disentangle the exact molecular events that result in 
these opposing results.  
 
Our data implies that the increased TEC compartment in Lin28bTEC animals relates to 
metabolic fitness and prolonged lifespan. Hence, experiments dissecting pro- and anti-
apoptotic pathways and further metabolic analyses of Lin28b tg TEC are required. 
 
Changes in TEC subset composition and TEC numbers in Lin28aTEC animals coincide 
with increased EMT and a defect in the up-regulation of WNT signaling in Lin28a tg TEC. As 
these two pathways are known to regulate TEC differentiation and TEC cellularity, it would 
be of interest to dissect WNT and EMT signaling in TEC that ectopically express Lin28a tg.  
 
Because the composition of cytometrically-defined mTEC subpopulations is 
significantly changed by Lin28a tg in young adult mice, more refined omics on a single cell 
resolution related to public data sets is required.  
 
The data shown in this thesis implies that ectopic Lin28a leads to enhanced glucose 
usage and reduced OxPhos by TEC. Hence, further characterization of glucose metabolism and 
mitochondrial biogenesis is needed to explore the mechanism behind these effects. 
 
Our results suggest that cTEClo and mTEC in Lin28aTEC mice are experiencing higher 
estrogen stimulation which result in increased TNF-R1 surface expression. It would therefore 
be of interest to elucidate the mechanistic link between estrogen signaling and TNF-R1 




The findings reported in this thesis make an important contribution in better 
understanding the role of Lin28a in thymus organogenesis, maintenance and function. 
Moreover, this study identifies mechanisms imposed by Lin28a in TEC biology. Collectively, 
our studies in a transgenic system provide novel insights into TEC metabolism, TEC apoptosis 
and thymocyte selection in wild-type animals and hence generate new knowledge that may be 
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